Arena Pharmaceuticals

99.99

0.0000

Volume:- -

Turnover:571.76M

Market Cap:6.17B

PE:-9.86

High:99.99

Open:99.99

Low:99.99

Close:99.99

Loading ...

Overview Company News Filings

Jan 11, 2021

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ARNA/filings?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ARNA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ARNA\",,,,,undefined,":{"symbol":"ARNA","market":"US","secType":"STK","nameCN":"Arena Pharmaceuticals","latestPrice":99.99,"timestamp":1646946000000,"preClose":99.99,"halted":3,"volume":0,"delay":0,"floatShares":61512993,"shares":61659385,"eps":-10.142704,"marketStatus":"Halted","change":0,"latestTime":"03-10 16:00:00 EST","open":99.99,"high":99.99,"low":99.99,"amount":571756101.86904,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-10.142704,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1753084800000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":964756800000,"exchange":"NASDAQ","adjPreClose":99.99,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ARNA\",,,,,undefined,":{"symbol":"ARNA","floatShares":61512993,"roa":"-34.53%","roe":"-70.30%","lyrEps":-10.142704,"shares":61659385,"dividePrice":0,"high":99.99,"amplitude":0,"preClose":99.99,"low":99.99,"week52Low":45.5,"pbRate":"9.16","week52High":100,"institutionHeld":0.8492,"latestPrice":99.99,"eps":-10.142704,"divideRate":0,"volume":0,"delay":0,"ttmEps":-10.142704,"open":99.99,"prevYearClose":92.94},"$inf$@#url:\"https://stock-news.skytigris.cn/v3/notice/important/events/list\",params:#symbol:\"ARNA\",pageSize:20,pageCount:4,market:\"us\",,,undefined,":[{"items":[{"cdn_pdf":false,"hasAttachments":true,"id":"11429505","market":"us","labels":[],"media":"sec.gov","original_id":"AN156459021000773-ARNA","pdf_url":null,"pub_time":1610294400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"8-K  - Current report","symbol":"ARNA","title":"8-K  - Current report","titleType":"Major Issues Report","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1080709/000156459021000773/0001564590-21-000773-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EX-99.1 - ARENA PHARMACEUTICALS CORPORATE PRESENTATION DATED JANUARY 2021","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459021000773/arna-ex991_6.htm","primary":true,"translateUrl":null,"linkName":"arna-ex991_6.htm","type":"EX-99.1","id":"NTFILEHzkQowWWAenBrfHf","market":"us","size":17370},{"description":"8-K - JPM DECK","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459021000773/arna-8k_20210111.htm","primary":false,"translateUrl":null,"linkName":"arna-8k_20210111.htm","type":"8-K","id":"NTFILEDjQck6XE4vTzqKYU","market":"us","size":39699},{"description":"GRAPHIC","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459021000773/slide-auatyum22io.jpg","primary":false,"translateUrl":null,"linkName":"slide-auatyum22io.jpg","type":"GRAPHIC","id":"NTFILEHzpSFQtHH2sRHHUP","market":"us","size":55703},{"description":"GRAPHIC","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459021000773/slide-2umdgoxfu5h.jpg","primary":false,"translateUrl":null,"linkName":"slide-2umdgoxfu5h.jpg","type":"GRAPHIC","id":"NTFILEHDsepC1c1SQf5JFb","market":"us","size":23614},{"description":"GRAPHIC","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459021000773/slide-eqkgxrhpnf2.jpg","primary":false,"translateUrl":null,"linkName":"slide-eqkgxrhpnf2.jpg","type":"GRAPHIC","id":"NTFILEDW2FXENCYZBo4JWh","market":"us","size":31217},{"description":"GRAPHIC","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459021000773/slide-ueeacr2easb.jpg","primary":false,"translateUrl":null,"linkName":"slide-ueeacr2easb.jpg","type":"GRAPHIC","id":"NTFILE7vkauLBBRT1swpJZ","market":"us","size":52780},{"description":"GRAPHIC","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459021000773/slide-5dr1pduyleu.jpg","primary":false,"translateUrl":null,"linkName":"slide-5dr1pduyleu.jpg","type":"GRAPHIC","id":"NTFILEHuazQuX3J5YGQKKj","market":"us","size":47441},{"description":"GRAPHIC","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459021000773/slide-vgobx1evaur.jpg","primary":false,"translateUrl":null,"linkName":"slide-vgobx1evaur.jpg","type":"GRAPHIC","id":"NTFILEFDsJBut7tQDefBGh","market":"us","size":57055},{"description":"GRAPHIC","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459021000773/slide-y2ayp2orf4j.jpg","primary":false,"translateUrl":null,"linkName":"slide-y2ayp2orf4j.jpg","type":"GRAPHIC","id":"NTFILEDvb6wYQ46Ep3mDYD","market":"us","size":63876},{"description":"GRAPHIC","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459021000773/slide-pmquc2ssh3e.jpg","primary":false,"translateUrl":null,"linkName":"slide-pmquc2ssh3e.jpg","type":"GRAPHIC","id":"NTFILE7QtdyUrxTvrdkP2e","market":"us","size":40907},{"description":"GRAPHIC","seq":11,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459021000773/slide-vshiqqyp2qm.jpg","primary":false,"translateUrl":null,"linkName":"slide-vshiqqyp2qm.jpg","type":"GRAPHIC","id":"NTFILE9yyTRTSZGruW8tQY","market":"us","size":46449},{"description":"GRAPHIC","seq":12,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459021000773/slide-cberqck3hxt.jpg","primary":false,"translateUrl":null,"linkName":"slide-cberqck3hxt.jpg","type":"GRAPHIC","id":"NTFILEnZ4K4BvU1sSLVuXo","market":"us","size":34446},{"description":"GRAPHIC","seq":13,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459021000773/slide-0scvobmrrdl.jpg","primary":false,"translateUrl":null,"linkName":"slide-0scvobmrrdl.jpg","type":"GRAPHIC","id":"NTFILE5uB6xXgJjpLVVBLe","market":"us","size":44502},{"description":"GRAPHIC","seq":14,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459021000773/slide-pl0hfhvwghd.jpg","primary":false,"translateUrl":null,"linkName":"slide-pl0hfhvwghd.jpg","type":"GRAPHIC","id":"NTFILEA7wdESF5bgzrg9YR","market":"us","size":22884},{"description":"GRAPHIC","seq":15,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459021000773/slide-gw15z5wgmev.jpg","primary":false,"translateUrl":null,"linkName":"slide-gw15z5wgmev.jpg","type":"GRAPHIC","id":"NTFILE3kruUznTowSq13tZ","market":"us","size":45956},{"description":"GRAPHIC","seq":16,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459021000773/slide-iiuoou5syp4.jpg","primary":false,"translateUrl":null,"linkName":"slide-iiuoou5syp4.jpg","type":"GRAPHIC","id":"NTFILE6S3LZZXpiUvJR1ZN","market":"us","size":40281},{"description":"GRAPHIC","seq":17,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459021000773/slide-pfbzcymwwwh.jpg","primary":false,"translateUrl":null,"linkName":"slide-pfbzcymwwwh.jpg","type":"GRAPHIC","id":"NTFILEDZbwNEjD28pQYkzF","market":"us","size":51960},{"description":"GRAPHIC","seq":18,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459021000773/slide-ctrl25unhnh.jpg","primary":false,"translateUrl":null,"linkName":"slide-ctrl25unhnh.jpg","type":"GRAPHIC","id":"NTFILE5jiobLkMhbxPdhVL","market":"us","size":40226},{"description":"GRAPHIC","seq":19,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459021000773/slide-n0uw5zkpcg0.jpg","primary":false,"translateUrl":null,"linkName":"slide-n0uw5zkpcg0.jpg","type":"GRAPHIC","id":"NTFILE8rTcLQu23d2uZK5U","market":"us","size":46913},{"description":"GRAPHIC","seq":20,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459021000773/slide-ewlwbovlult.jpg","primary":false,"translateUrl":null,"linkName":"slide-ewlwbovlult.jpg","type":"GRAPHIC","id":"NTFILE7WwtZ4EJXufafywi","market":"us","size":51746},{"description":"GRAPHIC","seq":21,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459021000773/slide-dupdntazf03.jpg","primary":false,"translateUrl":null,"linkName":"slide-dupdntazf03.jpg","type":"GRAPHIC","id":"NTFILECnq756uK3pMeScJq","market":"us","size":48657},{"description":"GRAPHIC","seq":22,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459021000773/slide-exhe0iu5qj4.jpg","primary":false,"translateUrl":null,"linkName":"slide-exhe0iu5qj4.jpg","type":"GRAPHIC","id":"NTFILEEjs7QZuTUkPmA5nQ","market":"us","size":33374},{"description":"GRAPHIC","seq":23,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459021000773/slide-czhsh54tg4z.jpg","primary":false,"translateUrl":null,"linkName":"slide-czhsh54tg4z.jpg","type":"GRAPHIC","id":"NTFILE2Sz6aPYPU5oDdR41","market":"us","size":103410}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Major Issues Report","pubTime":"2021-01-11 00:00","pubTimestamp":1610294400,"title_zh":"8-K  - Current report","summary_en":"Item 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"10884344","market":"us","labels":[],"media":"sec.gov","original_id":"AN156459020054462-ARNA","pdf_url":null,"pub_time":1605628800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"8-K  - Current report","symbol":"ARNA","title":"8-K  - Current report","titleType":"Major Issues Report","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020054462/0001564590-20-054462-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EX-99.1 - ARENA PHARMACEUTICALS CORPORATE SLIDE PRESENTATION DATED NOVEMBER 2020","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020054462/arna-ex991_24.htm","primary":true,"translateUrl":null,"linkName":"arna-ex991_24.htm","type":"EX-99.1","id":"NTFILEHJJMzrVqm2A6DJkJ","market":"us","size":38107},{"description":"8-K - NOVEMBER 2020 CORPORATE PRESENTATION","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020054462/arna-8k_20201118.htm","primary":false,"translateUrl":null,"linkName":"arna-8k_20201118.htm","type":"8-K","id":"NTFILEB6sFoeNxWRcv3hJh","market":"us","size":39873},{"description":"GRAPHIC","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020054462/gx1dh0qd5zzr000032.jpg","primary":false,"translateUrl":null,"linkName":"gx1dh0qd5zzr000032.jpg","type":"GRAPHIC","id":"NTFILEBhEKCVv8gzTtw1tS","market":"us","size":299810},{"description":"GRAPHIC","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020054462/gx1dh0qd5zzr000007.jpg","primary":false,"translateUrl":null,"linkName":"gx1dh0qd5zzr000007.jpg","type":"GRAPHIC","id":"NTFILE8aUZxzWDAveF6mhM","market":"us","size":238334},{"description":"GRAPHIC","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020054462/gx1dh0qd5zzr000008.jpg","primary":false,"translateUrl":null,"linkName":"gx1dh0qd5zzr000008.jpg","type":"GRAPHIC","id":"NTFILE56BQnADNZGVMy8Pb","market":"us","size":257804},{"description":"GRAPHIC","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020054462/gx1dh0qd5zzr000024.jpg","primary":false,"translateUrl":null,"linkName":"gx1dh0qd5zzr000024.jpg","type":"GRAPHIC","id":"NTFILEC3bFWReTcadcdcsa","market":"us","size":272663},{"description":"GRAPHIC","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020054462/gx1dh0qd5zzr000014.jpg","primary":false,"translateUrl":null,"linkName":"gx1dh0qd5zzr000014.jpg","type":"GRAPHIC","id":"NTFILE9k48xLwNwC3YiHc8","market":"us","size":246295},{"description":"GRAPHIC","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020054462/gx1dh0qd5zzr000003.jpg","primary":false,"translateUrl":null,"linkName":"gx1dh0qd5zzr000003.jpg","type":"GRAPHIC","id":"NTFILEDRstcAzzh8xP3xRq","market":"us","size":247073},{"description":"GRAPHIC","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020054462/gx1dh0qd5zzr000010.jpg","primary":false,"translateUrl":null,"linkName":"gx1dh0qd5zzr000010.jpg","type":"GRAPHIC","id":"NTFILE3mkR2JajpeaSaonf","market":"us","size":201882},{"description":"GRAPHIC","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020054462/gx1dh0qd5zzr000005.jpg","primary":false,"translateUrl":null,"linkName":"gx1dh0qd5zzr000005.jpg","type":"GRAPHIC","id":"NTFILEEgAfCiowJ54MHy84","market":"us","size":265943},{"description":"GRAPHIC","seq":11,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020054462/gx1dh0qd5zzr000015.jpg","primary":false,"translateUrl":null,"linkName":"gx1dh0qd5zzr000015.jpg","type":"GRAPHIC","id":"NTFILEBkUNp1CTMjKyqwRy","market":"us","size":264431},{"description":"GRAPHIC","seq":12,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020054462/gx1dh0qd5zzr000017.jpg","primary":false,"translateUrl":null,"linkName":"gx1dh0qd5zzr000017.jpg","type":"GRAPHIC","id":"NTFILEBHidc68hd3nRhPz8","market":"us","size":252556},{"description":"GRAPHIC","seq":13,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020054462/gx1dh0qd5zzr000009.jpg","primary":false,"translateUrl":null,"linkName":"gx1dh0qd5zzr000009.jpg","type":"GRAPHIC","id":"NTFILE5tVQR1QQVLNRFaef","market":"us","size":183572},{"description":"GRAPHIC","seq":14,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020054462/gx1dh0qd5zzr000022.jpg","primary":false,"translateUrl":null,"linkName":"gx1dh0qd5zzr000022.jpg","type":"GRAPHIC","id":"NTFILEZEbHvfxNJUTaeCaX","market":"us","size":186518},{"description":"GRAPHIC","seq":15,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020054462/gx1dh0qd5zzr000011.jpg","primary":false,"translateUrl":null,"linkName":"gx1dh0qd5zzr000011.jpg","type":"GRAPHIC","id":"NTFILEFxi8B7rc2sUPeA89","market":"us","size":168543},{"description":"GRAPHIC","seq":16,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020054462/gx1dh0qd5zzr000002.jpg","primary":false,"translateUrl":null,"linkName":"gx1dh0qd5zzr000002.jpg","type":"GRAPHIC","id":"NTFILE37kionPuMDBK3dhv","market":"us","size":553652},{"description":"GRAPHIC","seq":17,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020054462/gx1dh0qd5zzr000023.jpg","primary":false,"translateUrl":null,"linkName":"gx1dh0qd5zzr000023.jpg","type":"GRAPHIC","id":"NTFILECpyqR62XtFbarWE1","market":"us","size":194271},{"description":"GRAPHIC","seq":18,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020054462/gx1dh0qd5zzr000031.jpg","primary":false,"translateUrl":null,"linkName":"gx1dh0qd5zzr000031.jpg","type":"GRAPHIC","id":"NTFILEBetKkHXcY92Yoy49","market":"us","size":231110},{"description":"GRAPHIC","seq":19,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020054462/gx1dh0qd5zzr000025.jpg","primary":false,"translateUrl":null,"linkName":"gx1dh0qd5zzr000025.jpg","type":"GRAPHIC","id":"NTFILE83UnhqZUfKMRAnyc","market":"us","size":162105},{"description":"GRAPHIC","seq":20,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020054462/gx1dh0qd5zzr000035.jpg","primary":false,"translateUrl":null,"linkName":"gx1dh0qd5zzr000035.jpg","type":"GRAPHIC","id":"NTFILE8zXaDUBKELKPGd5L","market":"us","size":240385},{"description":"GRAPHIC","seq":21,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020054462/gx1dh0qd5zzr000026.jpg","primary":false,"translateUrl":null,"linkName":"gx1dh0qd5zzr000026.jpg","type":"GRAPHIC","id":"NTFILE3HPdUL1vcDdRkeTc","market":"us","size":233425},{"description":"GRAPHIC","seq":22,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020054462/gx1dh0qd5zzr000021.jpg","primary":false,"translateUrl":null,"linkName":"gx1dh0qd5zzr000021.jpg","type":"GRAPHIC","id":"NTFILEQFqy2RQ7jDZnTv5F","market":"us","size":190099},{"description":"GRAPHIC","seq":23,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020054462/gx1dh0qd5zzr000006.jpg","primary":false,"translateUrl":null,"linkName":"gx1dh0qd5zzr000006.jpg","type":"GRAPHIC","id":"NTFILEEGpuaBgEABiWoQ4Z","market":"us","size":182838},{"description":"GRAPHIC","seq":24,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020054462/gx1dh0qd5zzr000012.jpg","primary":false,"translateUrl":null,"linkName":"gx1dh0qd5zzr000012.jpg","type":"GRAPHIC","id":"NTFILECTa9fnGYrTNeogqb","market":"us","size":298213},{"description":"GRAPHIC","seq":25,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020054462/gx1dh0qd5zzr000016.jpg","primary":false,"translateUrl":null,"linkName":"gx1dh0qd5zzr000016.jpg","type":"GRAPHIC","id":"NTFILEBdWVakFeXP5qsL4d","market":"us","size":253501},{"description":"GRAPHIC","seq":26,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020054462/gx1dh0qd5zzr000001.jpg","primary":false,"translateUrl":null,"linkName":"gx1dh0qd5zzr000001.jpg","type":"GRAPHIC","id":"NTFILE5oxyUo1irFgtZEtL","market":"us","size":220004},{"description":"GRAPHIC","seq":27,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020054462/gx1dh0qd5zzr000033.jpg","primary":false,"translateUrl":null,"linkName":"gx1dh0qd5zzr000033.jpg","type":"GRAPHIC","id":"NTFILE5jVSKzmvL91FS4ZV","market":"us","size":176301},{"description":"GRAPHIC","seq":28,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020054462/gx1dh0qd5zzr000013.jpg","primary":false,"translateUrl":null,"linkName":"gx1dh0qd5zzr000013.jpg","type":"GRAPHIC","id":"NTFILEa2NXdtXvbhYXERs1","market":"us","size":309534},{"description":"GRAPHIC","seq":29,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020054462/gx1dh0qd5zzr000020.jpg","primary":false,"translateUrl":null,"linkName":"gx1dh0qd5zzr000020.jpg","type":"GRAPHIC","id":"NTFILECMFhQCdAceBxuice","market":"us","size":202195},{"description":"GRAPHIC","seq":30,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020054462/gx1dh0qd5zzr000029.jpg","primary":false,"translateUrl":null,"linkName":"gx1dh0qd5zzr000029.jpg","type":"GRAPHIC","id":"NTFILE5ENWH1Dp89hUQL2G","market":"us","size":209188},{"description":"GRAPHIC","seq":31,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020054462/gx1dh0qd5zzr000034.jpg","primary":false,"translateUrl":null,"linkName":"gx1dh0qd5zzr000034.jpg","type":"GRAPHIC","id":"NTFILE5w3hpSWxnZ7Ehh4M","market":"us","size":182449},{"description":"GRAPHIC","seq":32,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020054462/gx1dh0qd5zzr000028.jpg","primary":false,"translateUrl":null,"linkName":"gx1dh0qd5zzr000028.jpg","type":"GRAPHIC","id":"NTFILE9sffHdL5NjHi6U4z","market":"us","size":198123},{"description":"GRAPHIC","seq":33,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020054462/gx1dh0qd5zzr000018.jpg","primary":false,"translateUrl":null,"linkName":"gx1dh0qd5zzr000018.jpg","type":"GRAPHIC","id":"NTFILEF6Cv9WnWs6T3vGPg","market":"us","size":187766},{"description":"GRAPHIC","seq":34,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020054462/gx1dh0qd5zzr000027.jpg","primary":false,"translateUrl":null,"linkName":"gx1dh0qd5zzr000027.jpg","type":"GRAPHIC","id":"NTFILEFTuwZWjtReNM7YQb","market":"us","size":257211},{"description":"GRAPHIC","seq":35,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020054462/gx1dh0qd5zzr000030.jpg","primary":false,"translateUrl":null,"linkName":"gx1dh0qd5zzr000030.jpg","type":"GRAPHIC","id":"NTFILED8tdQtrBwCFb6yRm","market":"us","size":190296},{"description":"GRAPHIC","seq":36,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020054462/gx1dh0qd5zzr000019.jpg","primary":false,"translateUrl":null,"linkName":"gx1dh0qd5zzr000019.jpg","type":"GRAPHIC","id":"NTFILE59VKJMb1tVoeVAYB","market":"us","size":181256},{"description":"GRAPHIC","seq":37,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020054462/gx1dh0qd5zzr000004.jpg","primary":false,"translateUrl":null,"linkName":"gx1dh0qd5zzr000004.jpg","type":"GRAPHIC","id":"NTFILE12hM6XLFtpAzUCuC","market":"us","size":157537}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Major Issues Report","pubTime":"2020-11-18 00:00","pubTimestamp":1605628800,"title_zh":"8-K  - Current report","summary_en":"Item 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"10884343","market":"us","labels":[],"media":"sec.gov","original_id":"AN156459020052539-ARNA","pdf_url":null,"pub_time":1604851200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"10-Q  - Quarterly report [Sections 13 or 15(d)]","symbol":"ARNA","title":"10-Q  - Quarterly report [Sections 13 or 15(d)]","titleType":"Quarterly Report","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020052539/0001564590-20-052539-index.htm","us_notice_code":"Form 10-Q","us_title_en":"10-Q  - Quarterly report [Sections 13 or 15(d)]","is_important":0,"hasEarnInfos":true,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"10-Q","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020052539/arna-10q_20200930.htm","primary":true,"translateUrl":null,"linkName":"arna-10q_20200930.htm","type":"10-Q","id":"NTFILEG2xjDUsDQ3GFjD6A","market":"us","size":2177338},{"description":"EX-10.1","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020052539/arna-ex101_105.htm","primary":false,"translateUrl":null,"linkName":"arna-ex101_105.htm","type":"EX-10.1","id":"NTFILEFZRp6nFgme6Nsp6P","market":"us","size":140771},{"description":"EX-31.1","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020052539/arna-ex311_6.htm","primary":false,"translateUrl":null,"linkName":"arna-ex311_6.htm","type":"EX-31.1","id":"NTFILEDB93rXSRRH8vLRJZ","market":"us","size":15029},{"description":"EX-31.2","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020052539/arna-ex312_11.htm","primary":false,"translateUrl":null,"linkName":"arna-ex312_11.htm","type":"EX-31.2","id":"NTFILEApBxc4uSVxDoRVbv","market":"us","size":15421},{"description":"EX-32.1","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020052539/arna-ex321_12.htm","primary":false,"translateUrl":null,"linkName":"arna-ex321_12.htm","type":"EX-32.1","id":"NTFILE9MX9Gfw6Wa5HKRdv","market":"us","size":8839}],"type_name":"Financial Report","type_name_en":"Financial Report","titleTypeEn":"Quarterly Report","us_type":"财务报告","us_type_zh":"财务报告","earn_infos":[{"id":62036,"name":"Condensed Consolidated Balance Sheets","name_zh":null,"url":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020052539/R2.htm","cdn_url":"","translation_url":"","translate_status":0},{"id":62037,"name":"Condensed Consolidated Statements of Operations and Comprehensive Loss","name_zh":null,"url":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020052539/R3.htm","cdn_url":"","translation_url":"","translate_status":0},{"id":62038,"name":"Condensed Consolidated Statements of Stockholders' Equity","name_zh":null,"url":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020052539/R4.htm","cdn_url":"","translation_url":"","translate_status":0},{"id":62039,"name":"Condensed Consolidated Statements of Cash Flows","name_zh":"简明综合现金流量表","url":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020052539/R5.htm","cdn_url":"https://static.tigerbbs.com/14ff6ca32baaa48385cd5bb21ee44e11","translation_url":"https://static.tigerbbs.com/b274ac96b160e2b9ac3899ad49f69934","translate_status":1}],"event_type":"important_notice","event_name":"Quarterly Report","pubTime":"2020-11-09 00:00","pubTimestamp":1604851200,"title_zh":"10-Q  - Quarterly report [Sections 13 or 15(d","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"10884342","market":"us","labels":[],"media":"sec.gov","original_id":"AN156459020052500-ARNA","pdf_url":null,"pub_time":1604851200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"8-K  - Current report","symbol":"ARNA","title":"8-K  - Current report","titleType":"Major Issues Report","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020052500/0001564590-20-052500-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 2.02: Results of Operations and Financial Condition;\nItem 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EX-99.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020052500/arna-ex991_6.htm","primary":true,"translateUrl":null,"linkName":"arna-ex991_6.htm","type":"EX-99.1","id":"NTFILEEYCcbkPytNb12miU","market":"us","size":279540},{"description":"8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020052500/arna-8k_20201109.htm","primary":false,"translateUrl":null,"linkName":"arna-8k_20201109.htm","type":"8-K","id":"NTFILE4hadiw4iMLTBSgCh","market":"us","size":51267},{"description":"GRAPHIC","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020052500/gyenqgn5klse000001.jpg","primary":false,"translateUrl":null,"linkName":"gyenqgn5klse000001.jpg","type":"GRAPHIC","id":"NTFILEEuhDxKUEipWu3b61","market":"us","size":8392}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Major Issues Report","pubTime":"2020-11-09 00:00","pubTimestamp":1604851200,"title_zh":"8-K  - Current report","summary_en":"Item 2.02: Results of Operations and Financial Condition;\nItem 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"10630708","market":"us","labels":[],"media":"sec.gov","original_id":"AN156459020048172-ARNA","pdf_url":null,"pub_time":1603814400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"8-K  - Current report","symbol":"ARNA","title":"8-K  - Current report","titleType":"Major Issues Report","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020048172/0001564590-20-048172-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers;\nItem 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"8-K - LONGBOARD PHARMACEUTICALS","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020048172/arna-8k_20201027.htm","primary":true,"translateUrl":null,"linkName":"arna-8k_20201027.htm","type":"8-K","id":"NTFILEDQF7LMqf5Kdwkqta","market":"us","size":48306}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Major Issues Report","pubTime":"2020-10-28 00:00","pubTimestamp":1603814400,"title_zh":"8-K  - Current report","summary_en":"Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers;\nItem 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"10594838","market":"us","labels":[],"media":"sec.gov","original_id":"AN156459020047516-ARNA","pdf_url":null,"pub_time":1603641600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"8-K  - Current report","symbol":"ARNA","title":"8-K  - Current report","titleType":"Major Issues Report","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020047516/0001564590-20-047516-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EX-99.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020047516/arna-ex991_15.htm","primary":true,"translateUrl":null,"linkName":"arna-ex991_15.htm","type":"EX-99.1","id":"NTFILE3GyEfZHMokczeb5V","market":"us","size":40419},{"description":"8-K ATOPIC DERMATITIS OVERVIEW","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020047516/arna-8k_20201026.htm","primary":false,"translateUrl":null,"linkName":"arna-8k_20201026.htm","type":"8-K","id":"NTFILEAnA9ZEFgjpE5diH9","market":"us","size":39740},{"description":"GRAPHIC","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020047516/gomq3d2eig5g000014.jpg","primary":false,"translateUrl":null,"linkName":"gomq3d2eig5g000014.jpg","type":"GRAPHIC","id":"NTFILE2VPkskRWYTJVS1hx","market":"us","size":275428},{"description":"GRAPHIC","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020047516/gomq3d2eig5g000020.jpg","primary":false,"translateUrl":null,"linkName":"gomq3d2eig5g000020.jpg","type":"GRAPHIC","id":"NTFILE2o6C3NcpfWFGQQnK","market":"us","size":240531},{"description":"GRAPHIC","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020047516/gomq3d2eig5g000002.jpg","primary":false,"translateUrl":null,"linkName":"gomq3d2eig5g000002.jpg","type":"GRAPHIC","id":"NTFILEFasxrVmnRp8W1MJR","market":"us","size":553182},{"description":"GRAPHIC","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020047516/gomq3d2eig5g000016.jpg","primary":false,"translateUrl":null,"linkName":"gomq3d2eig5g000016.jpg","type":"GRAPHIC","id":"NTFILEDPiGtkmaAzdS35M2","market":"us","size":267232},{"description":"GRAPHIC","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020047516/gomq3d2eig5g000024.jpg","primary":false,"translateUrl":null,"linkName":"gomq3d2eig5g000024.jpg","type":"GRAPHIC","id":"NTFILE7RerYCweBy7K4wEK","market":"us","size":225002},{"description":"GRAPHIC","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020047516/gomq3d2eig5g000007.jpg","primary":false,"translateUrl":null,"linkName":"gomq3d2eig5g000007.jpg","type":"GRAPHIC","id":"NTFILECazrh8r9UMQqHGvc","market":"us","size":282589},{"description":"GRAPHIC","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020047516/gomq3d2eig5g000006.jpg","primary":false,"translateUrl":null,"linkName":"gomq3d2eig5g000006.jpg","type":"GRAPHIC","id":"NTFILE7KksbqjkEr1PgJQi","market":"us","size":262232},{"description":"GRAPHIC","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020047516/gomq3d2eig5g000004.jpg","primary":false,"translateUrl":null,"linkName":"gomq3d2eig5g000004.jpg","type":"GRAPHIC","id":"NTFILEBqxLufvaXXAm3QKp","market":"us","size":267563},{"description":"GRAPHIC","seq":11,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020047516/gomq3d2eig5g000010.jpg","primary":false,"translateUrl":null,"linkName":"gomq3d2eig5g000010.jpg","type":"GRAPHIC","id":"NTFILE5v39oMWiEsfJcQbX","market":"us","size":290081},{"description":"GRAPHIC","seq":12,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020047516/gomq3d2eig5g000032.jpg","primary":false,"translateUrl":null,"linkName":"gomq3d2eig5g000032.jpg","type":"GRAPHIC","id":"NTFILE4vjkBxrRS4DpvAya","market":"us","size":179388},{"description":"GRAPHIC","seq":13,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020047516/gomq3d2eig5g000022.jpg","primary":false,"translateUrl":null,"linkName":"gomq3d2eig5g000022.jpg","type":"GRAPHIC","id":"NTFILE6gUY2A4gpjcWvYWo","market":"us","size":268124},{"description":"GRAPHIC","seq":14,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020047516/gomq3d2eig5g000029.jpg","primary":false,"translateUrl":null,"linkName":"gomq3d2eig5g000029.jpg","type":"GRAPHIC","id":"NTFILE8tDsovErQ8JsgiJ9","market":"us","size":175775},{"description":"GRAPHIC","seq":15,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020047516/gomq3d2eig5g000027.jpg","primary":false,"translateUrl":null,"linkName":"gomq3d2eig5g000027.jpg","type":"GRAPHIC","id":"NTFILE7W1vtCJ6YG1SAmTw","market":"us","size":220497},{"description":"GRAPHIC","seq":16,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020047516/gomq3d2eig5g000021.jpg","primary":false,"translateUrl":null,"linkName":"gomq3d2eig5g000021.jpg","type":"GRAPHIC","id":"NTFILE9vcUTNd8chb4pqJg","market":"us","size":208447},{"description":"GRAPHIC","seq":17,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020047516/gomq3d2eig5g000015.jpg","primary":false,"translateUrl":null,"linkName":"gomq3d2eig5g000015.jpg","type":"GRAPHIC","id":"NTFILEF5nCFuuN21RJWVb7","market":"us","size":349758},{"description":"GRAPHIC","seq":18,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020047516/gomq3d2eig5g000003.jpg","primary":false,"translateUrl":null,"linkName":"gomq3d2eig5g000003.jpg","type":"GRAPHIC","id":"NTFILEejCGqPN4eGYbtQpD","market":"us","size":158858},{"description":"GRAPHIC","seq":19,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020047516/gomq3d2eig5g000028.jpg","primary":false,"translateUrl":null,"linkName":"gomq3d2eig5g000028.jpg","type":"GRAPHIC","id":"NTFILETo6amy4m9Ffu9zQH","market":"us","size":224172},{"description":"GRAPHIC","seq":20,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020047516/gomq3d2eig5g000031.jpg","primary":false,"translateUrl":null,"linkName":"gomq3d2eig5g000031.jpg","type":"GRAPHIC","id":"NTFILE4CbEC4GZP7v48hdu","market":"us","size":201357},{"description":"GRAPHIC","seq":21,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020047516/gomq3d2eig5g000025.jpg","primary":false,"translateUrl":null,"linkName":"gomq3d2eig5g000025.jpg","type":"GRAPHIC","id":"NTFILE3yXycVuAbJcogncT","market":"us","size":162817},{"description":"GRAPHIC","seq":22,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020047516/gomq3d2eig5g000001.jpg","primary":false,"translateUrl":null,"linkName":"gomq3d2eig5g000001.jpg","type":"GRAPHIC","id":"NTFILE2fSLdZG3FoAdsoNs","market":"us","size":228424},{"description":"GRAPHIC","seq":23,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020047516/gomq3d2eig5g000008.jpg","primary":false,"translateUrl":null,"linkName":"gomq3d2eig5g000008.jpg","type":"GRAPHIC","id":"NTFILE7xnaD56CyjBeKA11","market":"us","size":320956},{"description":"GRAPHIC","seq":24,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020047516/gomq3d2eig5g000026.jpg","primary":false,"translateUrl":null,"linkName":"gomq3d2eig5g000026.jpg","type":"GRAPHIC","id":"NTFILE2beEDaxaZUCPSfzQ","market":"us","size":339517},{"description":"GRAPHIC","seq":25,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020047516/gomq3d2eig5g000012.jpg","primary":false,"translateUrl":null,"linkName":"gomq3d2eig5g000012.jpg","type":"GRAPHIC","id":"NTFILEHM6fJzeQY6jdabgR","market":"us","size":291167},{"description":"GRAPHIC","seq":26,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020047516/gomq3d2eig5g000018.jpg","primary":false,"translateUrl":null,"linkName":"gomq3d2eig5g000018.jpg","type":"GRAPHIC","id":"NTFILEGYxXL9kX42PL3ARq","market":"us","size":197316},{"description":"GRAPHIC","seq":27,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020047516/gomq3d2eig5g000013.jpg","primary":false,"translateUrl":null,"linkName":"gomq3d2eig5g000013.jpg","type":"GRAPHIC","id":"NTFILEJYSXrTrN3EaHRPj6","market":"us","size":287975},{"description":"GRAPHIC","seq":28,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020047516/gomq3d2eig5g000023.jpg","primary":false,"translateUrl":null,"linkName":"gomq3d2eig5g000023.jpg","type":"GRAPHIC","id":"NTFILEFxb1was5ZqJ5zEsQ","market":"us","size":126388},{"description":"GRAPHIC","seq":29,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020047516/gomq3d2eig5g000019.jpg","primary":false,"translateUrl":null,"linkName":"gomq3d2eig5g000019.jpg","type":"GRAPHIC","id":"NTFILE2aXaESAcBw469KnM","market":"us","size":226777},{"description":"GRAPHIC","seq":30,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020047516/gomq3d2eig5g000005.jpg","primary":false,"translateUrl":null,"linkName":"gomq3d2eig5g000005.jpg","type":"GRAPHIC","id":"NTFILEAUKRawL8ktxEo7iW","market":"us","size":284896},{"description":"GRAPHIC","seq":31,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020047516/gomq3d2eig5g000030.jpg","primary":false,"translateUrl":null,"linkName":"gomq3d2eig5g000030.jpg","type":"GRAPHIC","id":"NTFILE2m2HLhb9ti8MQoe9","market":"us","size":185584},{"description":"GRAPHIC","seq":32,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020047516/gomq3d2eig5g000011.jpg","primary":false,"translateUrl":null,"linkName":"gomq3d2eig5g000011.jpg","type":"GRAPHIC","id":"NTFILEF9AjMLWkTsnAKBJL","market":"us","size":262910},{"description":"GRAPHIC","seq":33,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020047516/gomq3d2eig5g000009.jpg","primary":false,"translateUrl":null,"linkName":"gomq3d2eig5g000009.jpg","type":"GRAPHIC","id":"NTFILEEXwtzU3NdFgmgWdi","market":"us","size":257320},{"description":"GRAPHIC","seq":34,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020047516/gomq3d2eig5g000017.jpg","primary":false,"translateUrl":null,"linkName":"gomq3d2eig5g000017.jpg","type":"GRAPHIC","id":"NTFILE7Bx7fZE6LK3xZWq2","market":"us","size":224408}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Major Issues Report","pubTime":"2020-10-26 00:00","pubTimestamp":1603641600,"title_zh":"8-K  - Current report","summary_en":"Item 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"10395579","market":"us","labels":[],"media":"sec.gov","original_id":"AN156459020044366-ARNA","pdf_url":null,"pub_time":1600790400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"8-K  - Current report","symbol":"ARNA","title":"8-K  - Current report","titleType":"Major Issues Report","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020044366/0001564590-20-044366-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EX-99.1 PRESENTATION TITLED \"ETRASIMOD IBD PROGRAM UPDATE,\" DATED SEPTEMBER 2020","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020044366/arna-ex991_19.htm","primary":true,"translateUrl":null,"linkName":"arna-ex991_19.htm","type":"EX-99.1","id":"NTFILECxqob62TtroKvFJ2","market":"us","size":15645},{"description":"8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020044366/arna-8k_20200923.htm","primary":false,"translateUrl":null,"linkName":"arna-8k_20200923.htm","type":"8-K","id":"NTFILEAKgfEHd3NwpyYbD6","market":"us","size":39812},{"description":"GRAPHIC","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020044366/ghzf3iigheti000004.jpg","primary":false,"translateUrl":null,"linkName":"ghzf3iigheti000004.jpg","type":"GRAPHIC","id":"NTFILE87Xg8Eg1AM5mjzoe","market":"us","size":210192},{"description":"GRAPHIC","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020044366/ghzf3iigheti000006.jpg","primary":false,"translateUrl":null,"linkName":"ghzf3iigheti000006.jpg","type":"GRAPHIC","id":"NTFILE8zPXoau5SdcXq5pT","market":"us","size":272488},{"description":"GRAPHIC","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020044366/ghzf3iigheti000011.jpg","primary":false,"translateUrl":null,"linkName":"ghzf3iigheti000011.jpg","type":"GRAPHIC","id":"NTFILE6jjJT6xZyLxDs8RP","market":"us","size":296623},{"description":"GRAPHIC","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020044366/ghzf3iigheti000003.jpg","primary":false,"translateUrl":null,"linkName":"ghzf3iigheti000003.jpg","type":"GRAPHIC","id":"NTFILE8mDkSmG2SHtB38Aa","market":"us","size":239457},{"description":"GRAPHIC","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020044366/ghzf3iigheti000001.jpg","primary":false,"translateUrl":null,"linkName":"ghzf3iigheti000001.jpg","type":"GRAPHIC","id":"NTFILE97mvmGKWNMppPxLo","market":"us","size":231024},{"description":"GRAPHIC","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020044366/ghzf3iigheti000008.jpg","primary":false,"translateUrl":null,"linkName":"ghzf3iigheti000008.jpg","type":"GRAPHIC","id":"NTFILEEQm9CSVLxCLsJdmt","market":"us","size":171819},{"description":"GRAPHIC","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020044366/ghzf3iigheti000002.jpg","primary":false,"translateUrl":null,"linkName":"ghzf3iigheti000002.jpg","type":"GRAPHIC","id":"NTFILEDZ4hYG1Y3tVsAce1","market":"us","size":559233},{"description":"GRAPHIC","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020044366/ghzf3iigheti000007.jpg","primary":false,"translateUrl":null,"linkName":"ghzf3iigheti000007.jpg","type":"GRAPHIC","id":"NTFILE26fgsWLQumoxTKgh","market":"us","size":146066},{"description":"GRAPHIC","seq":11,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020044366/ghzf3iigheti000012.jpg","primary":false,"translateUrl":null,"linkName":"ghzf3iigheti000012.jpg","type":"GRAPHIC","id":"NTFILE7oKfQDrJcFKpL7jp","market":"us","size":180757},{"description":"GRAPHIC","seq":12,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020044366/ghzf3iigheti000013.jpg","primary":false,"translateUrl":null,"linkName":"ghzf3iigheti000013.jpg","type":"GRAPHIC","id":"NTFILEBjiErJMfB5kW3G5K","market":"us","size":173888},{"description":"GRAPHIC","seq":13,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020044366/ghzf3iigheti000009.jpg","primary":false,"translateUrl":null,"linkName":"ghzf3iigheti000009.jpg","type":"GRAPHIC","id":"NTFILE9uM9XBukKLJ3AZeW","market":"us","size":167739},{"description":"GRAPHIC","seq":14,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020044366/ghzf3iigheti000005.jpg","primary":false,"translateUrl":null,"linkName":"ghzf3iigheti000005.jpg","type":"GRAPHIC","id":"NTFILEHq936bosHMb6PQgk","market":"us","size":302080},{"description":"GRAPHIC","seq":15,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020044366/ghzf3iigheti000010.jpg","primary":false,"translateUrl":null,"linkName":"ghzf3iigheti000010.jpg","type":"GRAPHIC","id":"NTFILEG39YJgZsLX2Gr4Th","market":"us","size":154338},{"description":"XBRL TAXONOMY EXTENSION SCHEMA","seq":16,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020044366/arna-20200923.xsd","primary":false,"translateUrl":null,"linkName":"arna-20200923.xsd","type":"EX-101.SCH","id":"NTFILE4W1yvJLmSCr9AfS5","market":"us","size":5784},{"description":"XBRL TAXONOMY EXTENSION LABEL LINKBASE","seq":17,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020044366/arna-20200923_lab.xml","primary":false,"translateUrl":null,"linkName":"arna-20200923_lab.xml","type":"EX-101.LAB","id":"NTFILE9yte7PzZd11x6b3S","market":"us","size":18706},{"description":"XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE","seq":18,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020044366/arna-20200923_pre.xml","primary":false,"translateUrl":null,"linkName":"arna-20200923_pre.xml","type":"EX-101.PRE","id":"NTFILE3tf3mbASdSxkoJpp","market":"us","size":11179}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Major Issues Report","pubTime":"2020-09-23 00:00","pubTimestamp":1600790400,"title_zh":"8-K  - Current report","summary_en":"Item 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"10227658","market":"us","labels":[],"media":"sec.gov","original_id":"AN156459020036902-ARNA","pdf_url":null,"pub_time":1596556800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"10-Q  - Quarterly report [Sections 13 or 15(d)]","symbol":"ARNA","title":"10-Q  - Quarterly report [Sections 13 or 15(d)]","titleType":"Quarterly Report","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020036902/0001564590-20-036902-index.htm","us_notice_code":"Form 10-Q","us_title_en":"10-Q  - Quarterly report [Sections 13 or 15(d)]","is_important":0,"hasEarnInfos":true,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"10-Q","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020036902/arna-10q_20200630.htm","primary":true,"translateUrl":null,"linkName":"arna-10q_20200630.htm","type":"10-Q","id":"NTFILE85byepTrtL1cucC6","market":"us","size":2010803},{"description":"EX-10.1","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020036902/arna-ex101_148.htm","primary":false,"translateUrl":null,"linkName":"arna-ex101_148.htm","type":"EX-10.1","id":"NTFILEAHpKLKsD5eJt5TQr","market":"us","size":31766},{"description":"EX-10.2","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020036902/arna-ex102_395.htm","primary":false,"translateUrl":null,"linkName":"arna-ex102_395.htm","type":"EX-10.2","id":"NTFILE8N4hrhttrpwh2uJs","market":"us","size":146679},{"description":"EX-10.3","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020036902/arna-ex103_394.htm","primary":false,"translateUrl":null,"linkName":"arna-ex103_394.htm","type":"EX-10.3","id":"NTFILEEfrRJpLCHuaA8yui","market":"us","size":140771},{"description":"EX-10.8","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020036902/arna-ex108_393.htm","primary":false,"translateUrl":null,"linkName":"arna-ex108_393.htm","type":"EX-10.8","id":"NTFILE54dG9VZmmY3uQCVg","market":"us","size":53905},{"description":"EX-31.1","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020036902/arna-ex311_8.htm","primary":false,"translateUrl":null,"linkName":"arna-ex311_8.htm","type":"EX-31.1","id":"NTFILE3Lg8byD9TE53kLpn","market":"us","size":15027},{"description":"EX-31.2","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020036902/arna-ex312_6.htm","primary":false,"translateUrl":null,"linkName":"arna-ex312_6.htm","type":"EX-31.2","id":"NTFILE9Zv6uFpQeGTipzKZ","market":"us","size":15417},{"description":"EX-32.1","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020036902/arna-ex321_15.htm","primary":false,"translateUrl":null,"linkName":"arna-ex321_15.htm","type":"EX-32.1","id":"NTFILEau1tC7wmfzp8U5P3","market":"us","size":8830},{"description":"XBRL TAXONOMY EXTENSION SCHEMA","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020036902/arna-20200630.xsd","primary":false,"translateUrl":null,"linkName":"arna-20200630.xsd","type":"EX-101.SCH","id":"NTFILEAuzRFAbbwrigZFwW","market":"us","size":29636},{"description":"XBRL TAXONOMY EXTENSION CALCULATION LINKBASE","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020036902/arna-20200630_cal.xml","primary":false,"translateUrl":null,"linkName":"arna-20200630_cal.xml","type":"EX-101.CAL","id":"NTFILEAUL19qf3qz6cYojB","market":"us","size":39099},{"description":"XBRL TAXONOMY EXTENSION DEFINITION LINKBASE","seq":11,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020036902/arna-20200630_def.xml","primary":false,"translateUrl":null,"linkName":"arna-20200630_def.xml","type":"EX-101.DEF","id":"NTFILEEF3ZnhKoEGxUwGHp","market":"us","size":83087},{"description":"XBRL TAXONOMY EXTENSION LABEL LINKBASE","seq":12,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020036902/arna-20200630_lab.xml","primary":false,"translateUrl":null,"linkName":"arna-20200630_lab.xml","type":"EX-101.LAB","id":"NTFILEE2MqceWq14B63Bm2","market":"us","size":243335},{"description":"XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE","seq":13,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020036902/arna-20200630_pre.xml","primary":false,"translateUrl":null,"linkName":"arna-20200630_pre.xml","type":"EX-101.PRE","id":"NTFILEWtKWxvGu3vpZMJmj","market":"us","size":174685},{"description":"EXTRACTED XBRL INSTANCE DOCUMENT","seq":14,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020036902/arna-10q_20200630_htm.xml","primary":false,"translateUrl":null,"linkName":"arna-10q_20200630_htm.xml","type":"XML","id":"NTFILECgJeKe4E39DSnaBU","market":"us","size":1009101}],"type_name":"Financial Report","type_name_en":"Financial Report","titleTypeEn":"Quarterly Report","us_type":"财务报告","us_type_zh":"财务报告","earn_infos":[{"id":21187,"name":"Condensed Consolidated Balance Sheets","name_zh":null,"url":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020036902/R2.htm","cdn_url":"","translation_url":"","translate_status":0},{"id":21188,"name":"Condensed Consolidated Statements of Operations and Comprehensive Loss","name_zh":null,"url":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020036902/R3.htm","cdn_url":"","translation_url":"","translate_status":0},{"id":21189,"name":"Condensed Consolidated Statements of Stockholders' Equity","name_zh":null,"url":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020036902/R4.htm","cdn_url":"","translation_url":"","translate_status":0},{"id":21190,"name":"Condensed Consolidated Statements of Cash Flows","name_zh":"简明综合现金流量表","url":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020036902/R5.htm","cdn_url":"https://static.tigerbbs.com/1cade61af4eb1ef10a1d905eb7ac80c6","translation_url":"https://static.tigerbbs.com/aab01c8cbf07db076cd347540ddc8989","translate_status":1}],"event_type":"important_notice","event_name":"Quarterly Report","pubTime":"2020-08-05 00:00","pubTimestamp":1596556800,"title_zh":"10-Q  - Quarterly report [Sections 13 or 15(d","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"10226364","market":"us","labels":[],"media":"sec.gov","original_id":"AN156459020036786-ARNA","pdf_url":null,"pub_time":1596556800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"8-K  - Current report","symbol":"ARNA","title":"8-K  - Current report","titleType":"Major Issues Report","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020036786/0001564590-20-036786-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 2.02: Results of Operations and Financial Condition;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EX-99.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020036786/arna-ex991_6.htm","primary":true,"translateUrl":null,"linkName":"arna-ex991_6.htm","type":"EX-99.1","id":"NTFILEDdtvaozcncjoEgbJ","market":"us","size":269444},{"description":"8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020036786/arna-8k_20200805.htm","primary":false,"translateUrl":null,"linkName":"arna-8k_20200805.htm","type":"8-K","id":"NTFILE2AGbvskBNeBssFvy","market":"us","size":40613},{"description":"GRAPHIC","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020036786/g1pwfl2rz0ht000001.jpg","primary":false,"translateUrl":null,"linkName":"g1pwfl2rz0ht000001.jpg","type":"GRAPHIC","id":"NTFILE7XeRf7SnRkd7EKcf","market":"us","size":8392},{"description":"XBRL TAXONOMY EXTENSION SCHEMA","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020036786/arna-20200805.xsd","primary":false,"translateUrl":null,"linkName":"arna-20200805.xsd","type":"EX-101.SCH","id":"NTFILEHWmbj6Zybdf5V2Po","market":"us","size":5784},{"description":"XBRL TAXONOMY EXTENSION LABEL LINKBASE","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020036786/arna-20200805_lab.xml","primary":false,"translateUrl":null,"linkName":"arna-20200805_lab.xml","type":"EX-101.LAB","id":"NTFILE2TxZHdFvwyfJM8DN","market":"us","size":18708},{"description":"XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020036786/arna-20200805_pre.xml","primary":false,"translateUrl":null,"linkName":"arna-20200805_pre.xml","type":"EX-101.PRE","id":"NTFILEjvJaNCUonw2HbmYW","market":"us","size":11181},{"description":"EXTRACTED XBRL INSTANCE DOCUMENT","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020036786/arna-8k_20200805_htm.xml","primary":false,"translateUrl":null,"linkName":"arna-8k_20200805_htm.xml","type":"XML","id":"NTFILEA1E5RLtwhwJvBbJW","market":"us","size":3430}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Major Issues Report","pubTime":"2020-08-05 00:00","pubTimestamp":1596556800,"title_zh":"8-K  - Current report","summary_en":"Item 2.02: Results of Operations and Financial Condition;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"10009070","market":"us","labels":[],"media":"sec.gov","original_id":"AN156459020029991-ARNA","pdf_url":null,"pub_time":1592496000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"S-8  - Securities to be offered to employees in employee benefit plans","symbol":"ARNA","title":"S-8  - Securities to be offered to employees in employee benefit plans","titleType":"Employee Stock Ownership","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029991/0001564590-20-029991-index.htm","us_notice_code":"Form S-8","us_title_en":"S-8  - Securities to be offered to employees in employee benefit plans","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"S-8","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029991/arna-s8.htm","primary":true,"translateUrl":null,"linkName":"arna-s8.htm","type":"S-8","id":"NTFILEDcdaaqTrtesRzspw","market":"us","size":214617},{"description":"OPINION OF COOLEY LLP","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029991/arna-ex51_13.htm","primary":false,"translateUrl":null,"linkName":"arna-ex51_13.htm","type":"EX-5.1","id":"NTFILE8izVWeHbE55s42Vf","market":"us","size":14597},{"description":"CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029991/arna-ex231_6.htm","primary":false,"translateUrl":null,"linkName":"arna-ex231_6.htm","type":"EX-23.1","id":"NTFILE7ozxFmrbqmU1PNop","market":"us","size":2584},{"description":"ARENA PHARMACEUTICALS, INC. AMENDED AND RESTATED 2017 LONG-TERM INCENTIVE PLAN","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029991/arna-ex991_12.htm","primary":false,"translateUrl":null,"linkName":"arna-ex991_12.htm","type":"EX-99.1","id":"NTFILEDWY1LgMWVKJhGFp9","market":"us","size":146703},{"description":"ARENA PHARMACEUTICALS, INC. AMENDED AND RESTATED 2020 LONG-TERM INCENTIVE PLAN","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029991/arna-ex992_11.htm","primary":false,"translateUrl":null,"linkName":"arna-ex992_11.htm","type":"EX-99.2","id":"NTFILEEtHdHaDqXiBRbEB5","market":"us","size":140228},{"description":"FORM OF NONQUALIFIED STOCK OPTION GRANT AGREEMENT FOR EMPLOYEES AND CONSULTANTS","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029991/arna-ex993_10.htm","primary":false,"translateUrl":null,"linkName":"arna-ex993_10.htm","type":"EX-99.3","id":"NTFILEBKxXM3ymsW27h5Li","market":"us","size":39908},{"description":"FORM OF RESTRICTED STOCK UNIT GRANT AGREEMENT UNDER THE ARENA PHARMACEUTICALS, I","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029991/arna-ex994_9.htm","primary":false,"translateUrl":null,"linkName":"arna-ex994_9.htm","type":"EX-99.4","id":"NTFILE6kvFxH56UMUh88PK","market":"us","size":44210},{"description":"FORM OF RESTRICTED STOCK UNIT GRANT AGREEMENT FOR NON-EMPLOYEE DIRECTORS UNDER T","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029991/arna-ex995_8.htm","primary":false,"translateUrl":null,"linkName":"arna-ex995_8.htm","type":"EX-99.5","id":"NTFILEExwKQh566eVsD8kt","market":"us","size":55126},{"description":"FORM OF NONQUALIFIED STOCK OPTION GRANT AGREEMENT FOR NON-EMPLOYEE DIRECTORS UND","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029991/arna-ex996_7.htm","primary":false,"translateUrl":null,"linkName":"arna-ex996_7.htm","type":"EX-99.6","id":"NTFILEAr5Vb9PbUHepb1eZ","market":"us","size":40833},{"description":"GRAPHIC","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029991/g41np44ogqia000001.jpg","primary":false,"translateUrl":null,"linkName":"g41np44ogqia000001.jpg","type":"GRAPHIC","id":"NTFILEFxDHcaTmV9GaEVpJ","market":"us","size":28720}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Employee Stock Ownership","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Employee Stock Ownership","pubTime":"2020-06-19 00:00","pubTimestamp":1592496000,"title_zh":"S-8  - Securities to be offered to employees in employee benefit plans","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"10008770","market":"us","labels":[],"media":"sec.gov","original_id":"AN156459020029989-ARNA","pdf_url":null,"pub_time":1592496000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"S-8 POS  - Securities to be offered to employees in employee benefit plans, post-effective amendments","symbol":"ARNA","title":"S-8 POS  - Securities to be offered to employees in employee benefit plans, post-effective amendments","titleType":"Employee Stock Ownership","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029989/0001564590-20-029989-index.htm","us_notice_code":"Form S-8 POS","us_title_en":"S-8 POS  - Securities to be offered to employees in employee benefit plans, post-effective amendments","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"S-8 POS REGISTRATION NO. 333-189213","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029989/arna-s8pos.htm","primary":true,"translateUrl":null,"linkName":"arna-s8pos.htm","type":"S-8 POS","id":"NTFILE5f39PGnkfh9ow7rf","market":"us","size":188325},{"description":"OPINION OF COOLEY LLP","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029989/arna-ex51_7.htm","primary":false,"translateUrl":null,"linkName":"arna-ex51_7.htm","type":"EX-5.1","id":"NTFILEDChZzrPHQmPoWuJo","market":"us","size":17329},{"description":"CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029989/arna-ex231_11.htm","primary":false,"translateUrl":null,"linkName":"arna-ex231_11.htm","type":"EX-23.1","id":"NTFILEBfNYJ3Go1Uay58qS","market":"us","size":2586},{"description":"ARENA PHARMACEUTICALS, INC. AMENDED AND RESTATED 2017 LONG-TERM INCENTIVE PLAN","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029989/arna-ex994_8.htm","primary":false,"translateUrl":null,"linkName":"arna-ex994_8.htm","type":"EX-99.4","id":"NTFILEH27wyjUuE2nyKrAY","market":"us","size":146701},{"description":"ARENA PHARMACEUTICALS, INC. AMENDED AND RESTATED 2020 LONG-TERM INCENTIVE PLAN","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029989/arna-ex995_10.htm","primary":false,"translateUrl":null,"linkName":"arna-ex995_10.htm","type":"EX-99.5","id":"NTFILE4cUm32BwtEhhGLkV","market":"us","size":140228},{"description":"FORM OF NONQUALIFIED STOCK OPTION GRANT AGREEMENT FOR EMPLOYEES AND CONSULTANTS","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029989/arna-ex996_12.htm","primary":false,"translateUrl":null,"linkName":"arna-ex996_12.htm","type":"EX-99.6","id":"NTFILEGbdcDXnVpMPA8336","market":"us","size":39908},{"description":"FORM OF RESTRICTED STOCK UNIT GRANT AGREEMENT UNDER THE ARENA PHARMACEUTICALS, I","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029989/arna-ex997_9.htm","primary":false,"translateUrl":null,"linkName":"arna-ex997_9.htm","type":"EX-99.7","id":"NTFILE9YgT36kun46h1Zdm","market":"us","size":44210},{"description":"FORM OF RESTRICTED STOCK UNIT GRANT AGREEMENT FOR NON-EMPLOYEE DIRECTORS UNDER T","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029989/arna-ex998_6.htm","primary":false,"translateUrl":null,"linkName":"arna-ex998_6.htm","type":"EX-99.8","id":"NTFILEBJSxUKmz4NXacL7n","market":"us","size":55126},{"description":"FORM OF NONQUALIFIED STOCK OPTION GRANT AGREEMENT FOR NON-EMPLOYEE DIRECTORS UND","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029989/arna-ex999_13.htm","primary":false,"translateUrl":null,"linkName":"arna-ex999_13.htm","type":"EX-99.9","id":"NTFILE6ESiHNShZzhYqPEV","market":"us","size":40835},{"description":"GRAPHIC","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029989/g3jj1afhb1kr000001.jpg","primary":false,"translateUrl":null,"linkName":"g3jj1afhb1kr000001.jpg","type":"GRAPHIC","id":"NTFILE4vA7xtahvsxQ99nY","market":"us","size":28720}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Employee Stock Ownership","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Employee Stock Ownership","pubTime":"2020-06-19 00:00","pubTimestamp":1592496000,"title_zh":"S-8 POS  - Securities to be offered to employees in employee benefit plans, post-effective amendments","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"10008653","market":"us","labels":[],"media":"sec.gov","original_id":"AN156459020029986-ARNA","pdf_url":null,"pub_time":1592496000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"S-8 POS  - Securities to be offered to employees in employee benefit plans, post-effective amendments","symbol":"ARNA","title":"S-8 POS  - Securities to be offered to employees in employee benefit plans, post-effective amendments","titleType":"Employee Stock Ownership","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029986/0001564590-20-029986-index.htm","us_notice_code":"Form S-8 POS","us_title_en":"S-8 POS  - Securities to be offered to employees in employee benefit plans, post-effective amendments","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"S-8 POS REGISTRATION NO. 333-160329","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029986/arna-s8pos.htm","primary":true,"translateUrl":null,"linkName":"arna-s8pos.htm","type":"S-8 POS","id":"NTFILECyko9YeyiC5kjP9H","market":"us","size":188325},{"description":"OPINION OF COOLEY LLP","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029986/arna-ex51_9.htm","primary":false,"translateUrl":null,"linkName":"arna-ex51_9.htm","type":"EX-5.1","id":"NTFILE9qoEJ7quNHtoqaa9","market":"us","size":17329},{"description":"CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029986/arna-ex231_6.htm","primary":false,"translateUrl":null,"linkName":"arna-ex231_6.htm","type":"EX-23.1","id":"NTFILE7ofuRfCSDtp68P6G","market":"us","size":2584},{"description":"ARENA PHARMACEUTICALS, INC. AMENDED AND RESTATED 2017 LONG-TERM INCENTIVE PLAN","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029986/arna-ex994_10.htm","primary":false,"translateUrl":null,"linkName":"arna-ex994_10.htm","type":"EX-99.4","id":"NTFILEC75PNgbZ2SGewYdV","market":"us","size":146703},{"description":"ARENA PHARMACEUTICALS, INC. AMENDED AND RESTATED 2020 LONG-TERM INCENTIVE PLAN","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029986/arna-ex995_12.htm","primary":false,"translateUrl":null,"linkName":"arna-ex995_12.htm","type":"EX-99.5","id":"NTFILEHkVJ5Tb3iu67vjQd","market":"us","size":140228},{"description":"FORM OF NONQUALIFIED STOCK OPTION GRANT AGREEMENT FOR EMPLOYEES AND CONSULTANTS","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029986/arna-ex996_8.htm","primary":false,"translateUrl":null,"linkName":"arna-ex996_8.htm","type":"EX-99.6","id":"NTFILEFuGttNbMLQTigrKG","market":"us","size":39906},{"description":"FORM OF RESTRICTED STOCK UNIT GRANT AGREEMENT UNDER THE ARENA PHARMACEUTICALS, I","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029986/arna-ex997_7.htm","primary":false,"translateUrl":null,"linkName":"arna-ex997_7.htm","type":"EX-99.7","id":"NTFILECrzeWs24ueWFUzao","market":"us","size":44210},{"description":"FORM OF RESTRICTED STOCK UNIT GRANT AGREEMENT FOR NON-EMPLOYEE DIRECTORS UNDER T","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029986/arna-ex998_13.htm","primary":false,"translateUrl":null,"linkName":"arna-ex998_13.htm","type":"EX-99.8","id":"NTFILE5XiG3qHpnQ7eYiKL","market":"us","size":55128},{"description":"FORM OF NONQUALIFIED STOCK OPTION GRANT AGREEMENT FOR NON-EMPLOYEE DIRECTORS UND","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029986/arna-ex999_11.htm","primary":false,"translateUrl":null,"linkName":"arna-ex999_11.htm","type":"EX-99.9","id":"NTFILEBiRjFXZcVhx7YfCb","market":"us","size":40835},{"description":"GRAPHIC","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029986/g2ewmvv0fcnu000001.jpg","primary":false,"translateUrl":null,"linkName":"g2ewmvv0fcnu000001.jpg","type":"GRAPHIC","id":"NTFILECJ1kaSeyGmRQx7t2","market":"us","size":28720}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Employee Stock Ownership","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Employee Stock Ownership","pubTime":"2020-06-19 00:00","pubTimestamp":1592496000,"title_zh":"S-8 POS  - Securities to be offered to employees in employee benefit plans, post-effective amendments","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"10008652","market":"us","labels":[],"media":"sec.gov","original_id":"AN156459020029985-ARNA","pdf_url":null,"pub_time":1592496000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"S-8 POS  - Securities to be offered to employees in employee benefit plans, post-effective amendments","symbol":"ARNA","title":"S-8 POS  - Securities to be offered to employees in employee benefit plans, post-effective amendments","titleType":"Employee Stock Ownership","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029985/0001564590-20-029985-index.htm","us_notice_code":"Form S-8 POS","us_title_en":"S-8 POS  - Securities to be offered to employees in employee benefit plans, post-effective amendments","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"S-8 POS REGISTRATION NO. 333-214529","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029985/arna-s8pos.htm","primary":true,"translateUrl":null,"linkName":"arna-s8pos.htm","type":"S-8 POS","id":"NTFILEAX4v5QdGAhaargiq","market":"us","size":188325},{"description":"OPINION OF COOLEY LLP","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029985/arna-ex51_6.htm","primary":false,"translateUrl":null,"linkName":"arna-ex51_6.htm","type":"EX-5.1","id":"NTFILE2zhZdGpXxZpzW96U","market":"us","size":17329},{"description":"CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029985/arna-ex231_9.htm","primary":false,"translateUrl":null,"linkName":"arna-ex231_9.htm","type":"EX-23.1","id":"NTFILECSekQzXxRGUJbghX","market":"us","size":2584},{"description":"ARENA PHARMACEUTICALS, INC. AMENDED AND RESTATED 2017 LONG-TERM INCENTIVE PLAN","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029985/arna-ex994_13.htm","primary":false,"translateUrl":null,"linkName":"arna-ex994_13.htm","type":"EX-99.4","id":"NTFILEBJ2w1Nf2Eck749ND","market":"us","size":146703},{"description":"ARENA PHARMACEUTICALS, INC. AMENDED AND RESTATED 2020 LONG-TERM INCENTIVE PLAN","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029985/arna-ex995_10.htm","primary":false,"translateUrl":null,"linkName":"arna-ex995_10.htm","type":"EX-99.5","id":"NTFILE9kx4fayhWxRqByph","market":"us","size":140228},{"description":"FORM OF NONQUALIFIED STOCK OPTION GRANT AGREEMENT FOR EMPLOYEES AND CONSULTANTS","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029985/arna-ex996_8.htm","primary":false,"translateUrl":null,"linkName":"arna-ex996_8.htm","type":"EX-99.6","id":"NTFILEF76xassSa5Gswzgw","market":"us","size":39906},{"description":"FORM OF RESTRICTED STOCK UNIT GRANT AGREEMENT UNDER THE ARENA PHARMACEUTICALS, I","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029985/arna-ex997_7.htm","primary":false,"translateUrl":null,"linkName":"arna-ex997_7.htm","type":"EX-99.7","id":"NTFILECS84BjgCKRL4nrSq","market":"us","size":44210},{"description":"FORM OF RESTRICTED STOCK UNIT GRANT AGREEMENT FOR NON-EMPLOYEE DIRECTORS UNDER T","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029985/arna-ex998_11.htm","primary":false,"translateUrl":null,"linkName":"arna-ex998_11.htm","type":"EX-99.8","id":"NTFILEFCNgzzV9D3Bcx3XR","market":"us","size":55128},{"description":"FORM OF NONQUALIFIED STOCK OPTION GRANT AGREEMENT FOR NON-EMPLOYEE DIRECTORS UND","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029985/arna-ex999_12.htm","primary":false,"translateUrl":null,"linkName":"arna-ex999_12.htm","type":"EX-99.9","id":"NTFILE3kupTfucQFiC543r","market":"us","size":40835},{"description":"GRAPHIC","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029985/ghb0eblgftkw000001.jpg","primary":false,"translateUrl":null,"linkName":"ghb0eblgftkw000001.jpg","type":"GRAPHIC","id":"NTFILEB3xX8djXfBKpALFy","market":"us","size":28720}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Employee Stock Ownership","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Employee Stock Ownership","pubTime":"2020-06-19 00:00","pubTimestamp":1592496000,"title_zh":"S-8 POS  - Securities to be offered to employees in employee benefit plans, post-effective amendments","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"10008580","market":"us","labels":[],"media":"sec.gov","original_id":"AN156459020029984-ARNA","pdf_url":null,"pub_time":1592496000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"S-8 POS  - Securities to be offered to employees in employee benefit plans, post-effective amendments","symbol":"ARNA","title":"S-8 POS  - Securities to be offered to employees in employee benefit plans, post-effective amendments","titleType":"Employee Stock Ownership","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029984/0001564590-20-029984-index.htm","us_notice_code":"Form S-8 POS","us_title_en":"S-8 POS  - Securities to be offered to employees in employee benefit plans, post-effective amendments","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"S-8 POS REGISTRATION NO. 333-217805","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029984/arna-s8pos.htm","primary":true,"translateUrl":null,"linkName":"arna-s8pos.htm","type":"S-8 POS","id":"NTFILE9nMtYbRrnM7EaMJh","market":"us","size":188325},{"description":"OPINION OF COOLEY LLP","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029984/arna-ex51_9.htm","primary":false,"translateUrl":null,"linkName":"arna-ex51_9.htm","type":"EX-5.1","id":"NTFILE3HfZNiMUnHKM2EWR","market":"us","size":17329},{"description":"CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029984/arna-ex231_6.htm","primary":false,"translateUrl":null,"linkName":"arna-ex231_6.htm","type":"EX-23.1","id":"NTFILEGz1CqLnUJc2yWbV5","market":"us","size":2584},{"description":"ARENA PHARMACEUTICALS, INC. AMENDED AND RESTATED 2017 LONG-TERM INCENTIVE PLAN","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029984/arna-ex994_10.htm","primary":false,"translateUrl":null,"linkName":"arna-ex994_10.htm","type":"EX-99.4","id":"NTFILEAoGNfEMUM3KnmwNm","market":"us","size":146703},{"description":"ARENA PHARMACEUTICALS, INC. AMENDED AND RESTATED 2020 LONG-TERM INCENTIVE PLAN","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029984/arna-ex995_12.htm","primary":false,"translateUrl":null,"linkName":"arna-ex995_12.htm","type":"EX-99.5","id":"NTFILE8a9zNjnvakj6GNBx","market":"us","size":140228},{"description":"FORM OF NONQUALIFIED STOCK OPTION GRANT AGREEMENT FOR EMPLOYEES AND CONSULTANTS","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029984/arna-ex996_8.htm","primary":false,"translateUrl":null,"linkName":"arna-ex996_8.htm","type":"EX-99.6","id":"NTFILE12F9Vcb2Y5fkgkFi","market":"us","size":39906},{"description":"FORM OF RESTRICTED STOCK UNIT GRANT AGREEMENT UNDER THE ARENA PHARMACEUTICALS, I","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029984/arna-ex997_7.htm","primary":false,"translateUrl":null,"linkName":"arna-ex997_7.htm","type":"EX-99.7","id":"NTFILE9s5yq45ebwcoi7PA","market":"us","size":44210},{"description":"FORM OF RESTRICTED STOCK UNIT GRANT AGREEMENT FOR NON-EMPLOYEE DIRECTORS UNDER T","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029984/arna-ex998_13.htm","primary":false,"translateUrl":null,"linkName":"arna-ex998_13.htm","type":"EX-99.8","id":"NTFILE9rcfajJjMTaQ4e5H","market":"us","size":55128},{"description":"FORM OF NONQUALIFIED STOCK OPTION GRANT AGREEMENT FOR NON-EMPLOYEE DIRECTORS UND","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029984/arna-ex999_11.htm","primary":false,"translateUrl":null,"linkName":"arna-ex999_11.htm","type":"EX-99.9","id":"NTFILE3P3moL5Vpu8ijrL6","market":"us","size":40835},{"description":"GRAPHIC","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029984/ghftslagjza4000001.jpg","primary":false,"translateUrl":null,"linkName":"ghftslagjza4000001.jpg","type":"GRAPHIC","id":"NTFILE3aYMbfssAHPtKbBT","market":"us","size":28720}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Employee Stock Ownership","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Employee Stock Ownership","pubTime":"2020-06-19 00:00","pubTimestamp":1592496000,"title_zh":"S-8 POS  - Securities to be offered to employees in employee benefit plans, post-effective amendments","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"10008579","market":"us","labels":[],"media":"sec.gov","original_id":"AN156459020029982-ARNA","pdf_url":null,"pub_time":1592496000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"S-8 POS  - Securities to be offered to employees in employee benefit plans, post-effective amendments","symbol":"ARNA","title":"S-8 POS  - Securities to be offered to employees in employee benefit plans, post-effective amendments","titleType":"Employee Stock Ownership","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029982/0001564590-20-029982-index.htm","us_notice_code":"Form S-8 POS","us_title_en":"S-8 POS  - Securities to be offered to employees in employee benefit plans, post-effective amendments","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"S-8 POS REGISTRATION NO. 333-182238","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029982/arna-s8pos.htm","primary":true,"translateUrl":null,"linkName":"arna-s8pos.htm","type":"S-8 POS","id":"NTFILECPydWLA7CdKyMkEe","market":"us","size":188325},{"description":"OPINION OF COOLEY LLP","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029982/arna-ex51_7.htm","primary":false,"translateUrl":null,"linkName":"arna-ex51_7.htm","type":"EX-5.1","id":"NTFILE2sSkhnmhZmoZaj4H","market":"us","size":17329},{"description":"CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029982/arna-ex231_10.htm","primary":false,"translateUrl":null,"linkName":"arna-ex231_10.htm","type":"EX-23.1","id":"NTFILE4Rb4GGvfw9KTyQXb","market":"us","size":2586},{"description":"ARENA PHARMACEUTICALS, INC. AMENDED AND RESTATED 2017 LONG-TERM INCENTIVE PLAN","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029982/arna-ex994_6.htm","primary":false,"translateUrl":null,"linkName":"arna-ex994_6.htm","type":"EX-99.4","id":"NTFILE9f3khwQBPZRA4mJU","market":"us","size":146701},{"description":"ARENA PHARMACEUTICALS, INC. AMENDED AND RESTATED 2020 LONG-TERM INCENTIVE PLAN","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029982/arna-ex995_9.htm","primary":false,"translateUrl":null,"linkName":"arna-ex995_9.htm","type":"EX-99.5","id":"NTFILEDMTAcT3kTdiNKxNv","market":"us","size":140226},{"description":"FORM OF NONQUALIFIED STOCK OPTION GRANT AGREEMENT FOR EMPLOYEES AND CONSULTANTS","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029982/arna-ex996_13.htm","primary":false,"translateUrl":null,"linkName":"arna-ex996_13.htm","type":"EX-99.6","id":"NTFILEHxG3Nf9oCzmKMViY","market":"us","size":39908},{"description":"FORM OF RESTRICTED STOCK UNIT GRANT AGREEMENT UNDER THE ARENA PHARMACEUTICALS, I","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029982/arna-ex997_12.htm","primary":false,"translateUrl":null,"linkName":"arna-ex997_12.htm","type":"EX-99.7","id":"NTFILE2qdt81hNstptDBuX","market":"us","size":44212},{"description":"FORM OF RESTRICTED STOCK UNIT GRANT AGREEMENT FOR NON-EMPLOYEE DIRECTORS UNDER T","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029982/arna-ex998_8.htm","primary":false,"translateUrl":null,"linkName":"arna-ex998_8.htm","type":"EX-99.8","id":"NTFILEEBeeXSjGw5EwWTng","market":"us","size":55126},{"description":"FORM OF NONQUALIFIED STOCK OPTION GRANT AGREEMENT FOR NON-EMPLOYEE DIRECTORS UND","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029982/arna-ex999_11.htm","primary":false,"translateUrl":null,"linkName":"arna-ex999_11.htm","type":"EX-99.9","id":"NTFILEDqMtVg8F4XpFz6yv","market":"us","size":40835},{"description":"GRAPHIC","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029982/g3jj1afhb1kr000001.jpg","primary":false,"translateUrl":null,"linkName":"g3jj1afhb1kr000001.jpg","type":"GRAPHIC","id":"NTFILEBfukW1Kr9ugSqfJQ","market":"us","size":28720}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Employee Stock Ownership","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Employee Stock Ownership","pubTime":"2020-06-19 00:00","pubTimestamp":1592496000,"title_zh":"S-8 POS  - Securities to be offered to employees in employee benefit plans, post-effective amendments","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"10008424","market":"us","labels":[],"media":"sec.gov","original_id":"AN156459020029978-ARNA","pdf_url":null,"pub_time":1592496000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"S-8 POS  - Securities to be offered to employees in employee benefit plans, post-effective amendments","symbol":"ARNA","title":"S-8 POS  - Securities to be offered to employees in employee benefit plans, post-effective amendments","titleType":"Employee Stock Ownership","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029978/0001564590-20-029978-index.htm","us_notice_code":"Form S-8 POS","us_title_en":"S-8 POS  - Securities to be offered to employees in employee benefit plans, post-effective amendments","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"S-8 POS REGISTRATION NO. 333-212012","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029978/arna-s8pos.htm","primary":true,"translateUrl":null,"linkName":"arna-s8pos.htm","type":"S-8 POS","id":"NTFILE4MB7HjuYNQgmdf9s","market":"us","size":188325},{"description":"OPINION OF COOLEY LLP","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029978/arna-ex51_7.htm","primary":false,"translateUrl":null,"linkName":"arna-ex51_7.htm","type":"EX-5.1","id":"NTFILEHQUcVQvGhi7rqduM","market":"us","size":17329},{"description":"CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029978/arna-ex231_10.htm","primary":false,"translateUrl":null,"linkName":"arna-ex231_10.htm","type":"EX-23.1","id":"NTFILE6pk3jeCp2dx2YShy","market":"us","size":2586},{"description":"ARENA PHARMACEUTICALS, INC. AMENDED AND RESTATED 2017 LONG-TERM INCENTIVE PLAN","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029978/arna-ex994_11.htm","primary":false,"translateUrl":null,"linkName":"arna-ex994_11.htm","type":"EX-99.4","id":"NTFILEEwK8YRtSThGsXmyT","market":"us","size":146703},{"description":"ARENA PHARMACEUTICALS, INC. AMENDED AND RESTATED 2020 LONG-TERM INCENTIVE PLAN","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029978/arna-ex995_6.htm","primary":false,"translateUrl":null,"linkName":"arna-ex995_6.htm","type":"EX-99.5","id":"NTFILEDMqR29rYCmHkP7J2","market":"us","size":140226},{"description":"FORM OF NONQUALIFIED STOCK OPTION GRANT AGREEMENT FOR EMPLOYEES AND CONSULTANTS","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029978/arna-ex996_8.htm","primary":false,"translateUrl":null,"linkName":"arna-ex996_8.htm","type":"EX-99.6","id":"NTFILEHJSRBx36AS8huCJC","market":"us","size":39906},{"description":"FORM OF RESTRICTED STOCK UNIT GRANT AGREEMENT UNDER THE ARENA PHARMACEUTICALS, I","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029978/arna-ex997_13.htm","primary":false,"translateUrl":null,"linkName":"arna-ex997_13.htm","type":"EX-99.7","id":"NTFILE9SeJ5TvmhVfkmfb6","market":"us","size":44212},{"description":"FORM OF RESTRICTED STOCK UNIT GRANT AGREEMENT FOR NON-EMPLOYEE DIRECTORS UNDER T","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029978/arna-ex998_9.htm","primary":false,"translateUrl":null,"linkName":"arna-ex998_9.htm","type":"EX-99.8","id":"NTFILE3QsQxx3zoVW3TYDA","market":"us","size":55126},{"description":"FORM OF NONQUALIFIED STOCK OPTION GRANT AGREEMENT FOR NON-EMPLOYEE DIRECTORS UND","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029978/arna-ex999_12.htm","primary":false,"translateUrl":null,"linkName":"arna-ex999_12.htm","type":"EX-99.9","id":"NTFILEFwt5G4z9u4mpstpz","market":"us","size":40835},{"description":"GRAPHIC","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029978/g3jj1afhb1kr000001.jpg","primary":false,"translateUrl":null,"linkName":"g3jj1afhb1kr000001.jpg","type":"GRAPHIC","id":"NTFILEGaQVYdJKgVt8AYeH","market":"us","size":28720}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Employee Stock Ownership","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Employee Stock Ownership","pubTime":"2020-06-19 00:00","pubTimestamp":1592496000,"title_zh":"S-8 POS  - Securities to be offered to employees in employee benefit plans, post-effective amendments","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"10008423","market":"us","labels":[],"media":"sec.gov","original_id":"AN156459020029977-ARNA","pdf_url":null,"pub_time":1592496000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"S-8 POS  - Securities to be offered to employees in employee benefit plans, post-effective amendments","symbol":"ARNA","title":"S-8 POS  - Securities to be offered to employees in employee benefit plans, post-effective amendments","titleType":"Employee Stock Ownership","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029977/0001564590-20-029977-index.htm","us_notice_code":"Form S-8 POS","us_title_en":"S-8 POS  - Securities to be offered to employees in employee benefit plans, post-effective amendments","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"S-8 POS - REGISTRATION NO. 333-225608","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029977/arna-s8pos.htm","primary":true,"translateUrl":null,"linkName":"arna-s8pos.htm","type":"S-8 POS","id":"NTFILEFpVoVESw1ztF3Sod","market":"us","size":188328},{"description":"OPINION OF COOLEY LLP","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029977/arna-ex51_11.htm","primary":false,"translateUrl":null,"linkName":"arna-ex51_11.htm","type":"EX-5.1","id":"NTFILEBnbppk3FXE45ZU5D","market":"us","size":17331},{"description":"CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029977/arna-ex231_13.htm","primary":false,"translateUrl":null,"linkName":"arna-ex231_13.htm","type":"EX-23.1","id":"NTFILE5FnPPYWALWYv8Ksn","market":"us","size":2586},{"description":"ARENA PHARMACEUTICALS, INC. AMENDED AND RESTATED 2017 LONG-TERM INCENTIVE PLAN","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029977/arna-ex994_9.htm","primary":false,"translateUrl":null,"linkName":"arna-ex994_9.htm","type":"EX-99.4","id":"NTFILEGEreVyv8nfkSGN8c","market":"us","size":146701},{"description":"ARENA PHARMACEUTICALS, INC. AMENDED AND RESTATED 2020 LONG-TERM INCENTIVE PLAN","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029977/arna-ex995_6.htm","primary":false,"translateUrl":null,"linkName":"arna-ex995_6.htm","type":"EX-99.5","id":"NTFILEDtXjciMG665purqY","market":"us","size":140226},{"description":"FORM OF NONQUALIFIED STOCK OPTION GRANT AGREEMENT FOR EMPLOYEES AND CONSULTANTS","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029977/arna-ex996_12.htm","primary":false,"translateUrl":null,"linkName":"arna-ex996_12.htm","type":"EX-99.6","id":"NTFILE6NSjbBDUyFRoBAbk","market":"us","size":39908},{"description":"FORM OF RESTRICTED STOCK UNIT GRANT AGREEMENT UNDER THE ARENA PHARMACEUTICALS, I","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029977/arna-ex997_7.htm","primary":false,"translateUrl":null,"linkName":"arna-ex997_7.htm","type":"EX-99.7","id":"NTFILE5QE8x5sVZSaWpPop","market":"us","size":44210},{"description":"FORM OF RESTRICTED STOCK UNIT GRANT AGREEMENT FOR NON-EMPLOYEE DIRECTORS UNDER T","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029977/arna-ex998_8.htm","primary":false,"translateUrl":null,"linkName":"arna-ex998_8.htm","type":"EX-99.8","id":"NTFILE6BQH8cyM6kwsfCE9","market":"us","size":55126},{"description":"FORM OF NONQUALIFIED STOCK OPTION GRANT AGREEMENT FOR NON-EMPLOYEE DIRECTORS UND","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029977/arna-ex999_10.htm","primary":false,"translateUrl":null,"linkName":"arna-ex999_10.htm","type":"EX-99.9","id":"NTFILEBJ3TqhYjCjuia7xD","market":"us","size":40835},{"description":"GRAPHIC","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029977/gcdwduwkkztr000001.jpg","primary":false,"translateUrl":null,"linkName":"gcdwduwkkztr000001.jpg","type":"GRAPHIC","id":"NTFILEDrFCFXP2TQyn1ojc","market":"us","size":28720}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Employee Stock Ownership","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Employee Stock Ownership","pubTime":"2020-06-19 00:00","pubTimestamp":1592496000,"title_zh":"S-8 POS  - Securities to be offered to employees in employee benefit plans, post-effective amendments","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"10008321","market":"us","labels":[],"media":"sec.gov","original_id":"AN156459020029972-ARNA","pdf_url":null,"pub_time":1592496000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"S-8 POS  - Securities to be offered to employees in employee benefit plans, post-effective amendments","symbol":"ARNA","title":"S-8 POS  - Securities to be offered to employees in employee benefit plans, post-effective amendments","titleType":"Employee Stock Ownership","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029972/0001564590-20-029972-index.htm","us_notice_code":"Form S-8 POS","us_title_en":"S-8 POS  - Securities to be offered to employees in employee benefit plans, post-effective amendments","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"S-8 POS REGISTRATION NO. 333-218905","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029972/arna-s8pos.htm","primary":true,"translateUrl":null,"linkName":"arna-s8pos.htm","type":"S-8 POS","id":"NTFILE5tp41gJXCuiEjtWz","market":"us","size":188326},{"description":"OPINION OF COOLEY LLP","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029972/arna-ex51_10.htm","primary":false,"translateUrl":null,"linkName":"arna-ex51_10.htm","type":"EX-5.1","id":"NTFILE3Ysmv62uRN5uzTtS","market":"us","size":17331},{"description":"CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029972/arna-ex231_8.htm","primary":false,"translateUrl":null,"linkName":"arna-ex231_8.htm","type":"EX-23.1","id":"NTFILE7Gk5wteKvddPR9jx","market":"us","size":2584},{"description":"ARENA PHARMACEUTICALS, INC. AMENDED AND RESTATED 2017 LONG-TERM INCENTIVE PLAN","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029972/arna-ex994_11.htm","primary":false,"translateUrl":null,"linkName":"arna-ex994_11.htm","type":"EX-99.4","id":"NTFILEjopNBAGbDfdi4TSi","market":"us","size":146703},{"description":"ARENA PHARMACEUTICALS, INC. AMENDED AND RESTATED 2020 LONG-TERM INCENTIVE PLAN","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029972/arna-ex995_12.htm","primary":false,"translateUrl":null,"linkName":"arna-ex995_12.htm","type":"EX-99.5","id":"NTFILEQJtx3yTia5o2bJ4R","market":"us","size":140228},{"description":"FORM OF NONQUALIFIED STOCK OPTION GRANT AGREEMENT FOR EMPLOYEES AND CONSULTANTS","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029972/arna-ex996_13.htm","primary":false,"translateUrl":null,"linkName":"arna-ex996_13.htm","type":"EX-99.6","id":"NTFILE5JxttYPzEHR3xkqm","market":"us","size":39908},{"description":"FORM OF RESTRICTED STOCK UNIT GRANT AGREEMENT UNDER THE ARENA PHARMACEUTICALS, I","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029972/arna-ex997_6.htm","primary":false,"translateUrl":null,"linkName":"arna-ex997_6.htm","type":"EX-99.7","id":"NTFILEGxsa7nacAYZoWG2U","market":"us","size":44210},{"description":"FORM OF RESTRICTED STOCK UNIT GRANT AGREEMENT FOR NON-EMPLOYEE DIRECTORS UNDER T","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029972/arna-ex998_7.htm","primary":false,"translateUrl":null,"linkName":"arna-ex998_7.htm","type":"EX-99.8","id":"NTFILE9pKm87V4s7rdvWbz","market":"us","size":55126},{"description":"FORM OF NONQUALIFIED STOCK OPTION GRANT AGREEMENT FOR NON-EMPLOYEE DIRECTORS UND","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029972/arna-ex999_9.htm","primary":false,"translateUrl":null,"linkName":"arna-ex999_9.htm","type":"EX-99.9","id":"NTFILE775xqmbEtB3Ca4k8","market":"us","size":40833},{"description":"GRAPHIC","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029972/giv5xm11r5zy000001.jpg","primary":false,"translateUrl":null,"linkName":"giv5xm11r5zy000001.jpg","type":"GRAPHIC","id":"NTFILEBw8xB1Tku9uSLzS9","market":"us","size":28720}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Employee Stock Ownership","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Employee Stock Ownership","pubTime":"2020-06-19 00:00","pubTimestamp":1592496000,"title_zh":"S-8 POS  - Securities to be offered to employees in employee benefit plans, post-effective amendments","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"10008310","market":"us","labels":[],"media":"sec.gov","original_id":"AN156459020029970-ARNA","pdf_url":null,"pub_time":1592496000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"S-8 POS  - Securities to be offered to employees in employee benefit plans, post-effective amendments","symbol":"ARNA","title":"S-8 POS  - Securities to be offered to employees in employee benefit plans, post-effective amendments","titleType":"Employee Stock Ownership","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029970/0001564590-20-029970-index.htm","us_notice_code":"Form S-8 POS","us_title_en":"S-8 POS  - Securities to be offered to employees in employee benefit plans, post-effective amendments","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"S-8 POS - REGISTRATION NO. 333-232142","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029970/arna-s8pos.htm","primary":true,"translateUrl":null,"linkName":"arna-s8pos.htm","type":"S-8 POS","id":"NTFILEHDLU8X4S5pwtwDJz","market":"us","size":188328},{"description":"OPINION OF COOLEY LLP","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029970/arna-ex51_13.htm","primary":false,"translateUrl":null,"linkName":"arna-ex51_13.htm","type":"EX-5.1","id":"NTFILEFSiqjEVgjN6f9Ep4","market":"us","size":17331},{"description":"CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029970/arna-ex231_12.htm","primary":false,"translateUrl":null,"linkName":"arna-ex231_12.htm","type":"EX-23.1","id":"NTFILE73ifmsyjsNhc2BgC","market":"us","size":2586},{"description":"ARENA PHARMACEUTICALS, INC. AMENDED AND RESTATED 2017 LONG-TERM INCENTIVE PLAN","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029970/arna-ex994_11.htm","primary":false,"translateUrl":null,"linkName":"arna-ex994_11.htm","type":"EX-99.4","id":"NTFILECPpWgHbkXtuXx9Z3","market":"us","size":146703},{"description":"ARENA PHARMACEUTICALS, INC. AMENDED AND RESTATED 2020 LONG-TERM INCENTIVE PLAN","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029970/arna-ex995_10.htm","primary":false,"translateUrl":null,"linkName":"arna-ex995_10.htm","type":"EX-99.5","id":"NTFILEGG8a9SKq5XB2taBd","market":"us","size":140228},{"description":"FORM OF NONQUALIFIED STOCK OPTION GRANT AGREEMENT FOR EMPLOYEES AND CONSULTANTS","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029970/arna-ex996_9.htm","primary":false,"translateUrl":null,"linkName":"arna-ex996_9.htm","type":"EX-99.6","id":"NTFILE4xCkMYGYCMEsC8Cy","market":"us","size":39906},{"description":"FORM OF RESTRICTED STOCK UNIT GRANT AGREEMENT UNDER THE ARENA PHARMACEUTICALS, I","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029970/arna-ex997_8.htm","primary":false,"translateUrl":null,"linkName":"arna-ex997_8.htm","type":"EX-99.7","id":"NTFILEEc9xF9QViy4qdHCS","market":"us","size":44210},{"description":"FORM OF RESTRICTED STOCK UNIT GRANT AGREEMENT FOR NON-EMPLOYEE DIRECTORS UNDER T","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029970/arna-ex998_7.htm","primary":false,"translateUrl":null,"linkName":"arna-ex998_7.htm","type":"EX-99.8","id":"NTFILECfmr1gG81VPkjueo","market":"us","size":55126},{"description":"FORM OF NONQUALIFIED STOCK OPTION GRANT AGREEMENT FOR NON-EMPLOYEE DIRECTORS UND","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029970/arna-ex999_6.htm","primary":false,"translateUrl":null,"linkName":"arna-ex999_6.htm","type":"EX-99.9","id":"NTFILE2g3y6LUnw6ZjonWo","market":"us","size":40833},{"description":"GRAPHIC","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029970/gpt2raqmz4bz000001.jpg","primary":false,"translateUrl":null,"linkName":"gpt2raqmz4bz000001.jpg","type":"GRAPHIC","id":"NTFILE8wTrYDFMX3wspqLA","market":"us","size":28720}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Employee Stock Ownership","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Employee Stock Ownership","pubTime":"2020-06-19 00:00","pubTimestamp":1592496000,"title_zh":"S-8 POS  - Securities to be offered to employees in employee benefit plans, post-effective amendments","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"9932245","market":"us","labels":[],"media":"sec.gov","original_id":"AN156459020029543-ARNA","pdf_url":null,"pub_time":1592236800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"8-K  - Current report","symbol":"ARNA","title":"8-K  - Current report","titleType":"Major Issues Report","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029543/0001564590-20-029543-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers;\nItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year;\nItem 5.07: Submission of Matters to a Vote of Security Holders;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"CERTIFICATE OF AMENDMENT NO. 5 OF THE FIFTH AMENDED AND RESTATED CERTIFICATE OF","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029543/arna-ex31_7.htm","primary":true,"translateUrl":null,"linkName":"arna-ex31_7.htm","type":"EX-3.1","id":"NTFILE2Jb7Wkc6it5ug6Dm","market":"us","size":8013},{"description":"8-K - 2020 ANNUAL MEETING","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029543/arna-8k_20200612.htm","primary":false,"translateUrl":null,"linkName":"arna-8k_20200612.htm","type":"8-K","id":"NTFILEBtY1mN8MGsnPvQsP","market":"us","size":102924},{"description":"AMENDED AND RESTATED BYLAWS OF ARENA","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029543/arna-ex32_6.htm","primary":false,"translateUrl":null,"linkName":"arna-ex32_6.htm","type":"EX-3.2","id":"NTFILEAJJkwjZDNxNTC54B","market":"us","size":108556},{"description":"XBRL TAXONOMY EXTENSION SCHEMA","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029543/arna-20200612.xsd","primary":false,"translateUrl":null,"linkName":"arna-20200612.xsd","type":"EX-101.SCH","id":"NTFILE9Gik9aTNKYiKmQDy","market":"us","size":5784},{"description":"XBRL TAXONOMY EXTENSION LABEL LINKBASE","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029543/arna-20200612_lab.xml","primary":false,"translateUrl":null,"linkName":"arna-20200612_lab.xml","type":"EX-101.LAB","id":"NTFILE3b5pdkF8LQBub7J9","market":"us","size":19459},{"description":"XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029543/arna-20200612_pre.xml","primary":false,"translateUrl":null,"linkName":"arna-20200612_pre.xml","type":"EX-101.PRE","id":"NTFILEEm6qDA1ZXwKMcc3A","market":"us","size":11633},{"description":"EXTRACTED XBRL INSTANCE DOCUMENT","seq":15,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1080709/000156459020029543/arna-8k_20200612_htm.xml","primary":false,"translateUrl":null,"linkName":"arna-8k_20200612_htm.xml","type":"XML","id":"NTFILEJA5R4QSYVwRd76jK","market":"us","size":3561}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Major Issues Report","pubTime":"2020-06-16 00:00","pubTimestamp":1592236800,"title_zh":"8-K  - Current report","summary_en":"Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers;\nItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year;\nItem 5.07: Submission of Matters to a Vote of Security Holders;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":4,"totalSize":150,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ARNA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2022-03-14","symbol":"ARNA","reason":null,"defaultRemindTime":1647264600000,"announcedDate":"2022-03-10","type":"delisting","dateTimestamp":1647230400000},{"market":"US","date":"2022-02-23","symbol":"ARNA","fiscalQuarterEnding":"2021/12","expectedEps":-2.41,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1645592400000,"reportTimeType":"post","actualEps":-2.54},{"market":"US","date":"2021-11-04","symbol":"ARNA","fiscalQuarterEnding":"2021/09","expectedEps":-2.42,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1635998400000,"reportTimeType":"post","actualEps":-3.21},{"market":"US","date":"2021-08-05","symbol":"ARNA","fiscalQuarterEnding":"2021/06","expectedEps":-2.21,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1628136000000,"reportTimeType":"post","actualEps":-2.4},{"market":"US","date":"2021-05-05","symbol":"ARNA","fiscalQuarterEnding":"2021/03","expectedEps":-2.19,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1620187200000,"reportTimeType":"post","actualEps":-1.98}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ARNA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ARNA\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ARNA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ARNA","date":"2022-03-11","current":-10.001609,"percent":0.649799,"low":-122.604036,"twenty":-42.451867,"median":-12.163161,"eighty":-8.385663,"high":6.523119,"avg":-25.442075,"sd":28.935228,"marketCap":6165321906},"quantilePoints":[{"date":"2020-07-24","current":-10.940674,"twenty":-38.27406,"median":-11.23447,"eighty":-4.506314,"marketCap":3531496302},{"date":"2020-07-31","current":-10.768766,"twenty":-37.992771,"median":-11.192267,"eighty":-4.506314,"marketCap":3476007022},{"date":"2020-08-07","current":-10.531926,"twenty":-30.906373,"median":-11.143279,"eighty":-4.506314,"marketCap":3647321703},{"date":"2020-08-14","current":-10.585193,"twenty":-30.906373,"median":-11.069604,"eighty":-4.506314,"marketCap":3665768723},{"date":"2020-08-21","current":-11.117865,"twenty":-30.906373,"median":-11.065219,"eighty":-4.506314,"marketCap":3850238922},{"date":"2020-08-28","current":-11.715456,"twenty":-30.906373,"median":-11.069604,"eighty":-4.506314,"marketCap":4057191426},{"date":"2020-09-04","current":-10.829889,"twenty":-30.906373,"median":-11.065219,"eighty":-4.506314,"marketCap":3750509721},{"date":"2020-09-11","current":-10.548572,"twenty":-30.906373,"median":-11.016979,"eighty":-4.506314,"marketCap":3653086397},{"date":"2020-09-18","current":-11.860277,"twenty":-30.906373,"median":-11.016979,"eighty":-4.506314,"marketCap":4107344261},{"date":"2020-09-25","current":-12.266439,"twenty":-30.906373,"median":-11.069604,"eighty":-4.506314,"marketCap":4248002787},{"date":"2020-10-02","current":-12.481173,"twenty":-30.906373,"median":-11.139427,"eighty":-4.506314,"marketCap":4322367336},{"date":"2020-10-09","current":-13.744604,"twenty":-30.906373,"median":-11.166308,"eighty":-4.506314,"marketCap":4759907588},{"date":"2020-10-16","current":-13.469945,"twenty":-30.906373,"median":-11.245897,"eighty":-4.506314,"marketCap":4664790142},{"date":"2020-10-23","current":-13.539858,"twenty":-30.906373,"median":-11.290707,"eighty":-4.506314,"marketCap":4689001855},{"date":"2020-10-30","current":-14.268953,"twenty":-30.906373,"median":-11.341499,"eighty":-4.506314,"marketCap":4941495439},{"date":"2020-11-06","current":-14.422096,"twenty":-30.906373,"median":-11.382671,"eighty":-4.506314,"marketCap":4994530621},{"date":"2020-11-13","current":-10.457116,"twenty":-30.906373,"median":-11.405013,"eighty":-4.506314,"marketCap":3878376986},{"date":"2020-11-20","current":-10.166989,"twenty":-30.906373,"median":-11.405013,"eighty":-4.506314,"marketCap":3770773546},{"date":"2020-11-27","current":-10.334792,"twenty":-30.906373,"median":-11.405013,"eighty":-4.506314,"marketCap":3833009049},{"date":"2020-12-04","current":-10.515141,"twenty":-30.906373,"median":-11.405013,"eighty":-4.506314,"marketCap":3899897675},{"date":"2020-12-11","current":-10.850748,"twenty":-30.906373,"median":-11.405013,"eighty":-4.506314,"marketCap":4024368682},{"date":"2020-12-18","current":-11.325929,"twenty":-30.906373,"median":-11.405013,"eighty":-4.506314,"marketCap":4200605668},{"date":"2020-12-24","current":-12.244925,"twenty":-30.906373,"median":-11.458629,"eighty":-4.506314,"marketCap":4541446837},{"date":"2020-12-31","current":-12.172786,"twenty":-30.906373,"median":-11.51075,"eighty":-4.506314,"marketCap":4514691387},{"date":"2021-01-08","current":-12.168081,"twenty":-30.984655,"median":-11.530468,"eighty":-4.488598,"marketCap":4512946466},{"date":"2021-01-15","current":-12.633852,"twenty":-30.984655,"median":-11.628898,"eighty":-4.488598,"marketCap":4685693612},{"date":"2021-01-22","current":-12.022233,"twenty":-30.984655,"median":-11.69703,"eighty":-4.488598,"marketCap":4458853926},{"date":"2021-01-29","current":-12.153966,"twenty":-30.984655,"median":-11.755958,"eighty":-4.488598,"marketCap":4507711705},{"date":"2021-02-05","current":-12.624443,"twenty":-39.027721,"median":-11.836515,"eighty":-4.485633,"marketCap":4682203771},{"date":"2021-02-12","current":-13.036893,"twenty":-39.027721,"median":-11.984596,"eighty":-4.485633,"marketCap":4835175148},{"date":"2021-02-19","current":-12.619738,"twenty":-39.027721,"median":-12.052872,"eighty":-4.485633,"marketCap":4680458850},{"date":"2021-02-26","current":-11.849761,"twenty":-39.027721,"median":-12.103738,"eighty":-4.485633,"marketCap":4796001169},{"date":"2021-03-05","current":-10.660164,"twenty":-41.038487,"median":-12.109967,"eighty":-4.484892,"marketCap":4314530678},{"date":"2021-03-12","current":-11.278814,"twenty":-41.038487,"median":-12.109967,"eighty":-4.484892,"marketCap":4564919467},{"date":"2021-03-19","current":-10.864393,"twenty":-41.321163,"median":-12.131967,"eighty":-4.484877,"marketCap":4397189146},{"date":"2021-03-26","current":-10.525999,"twenty":-41.038487,"median":-12.109967,"eighty":-4.484892,"marketCap":4260229495},{"date":"2021-04-01","current":-10.34413,"twenty":-41.038487,"median":-12.109967,"eighty":-4.484892,"marketCap":4186621224},{"date":"2021-04-09","current":-9.91182,"twenty":-41.321163,"median":-12.131967,"eighty":-4.484877,"marketCap":4011650745},{"date":"2021-04-15","current":-10.083254,"twenty":-41.321163,"median":-12.131967,"eighty":-4.484877,"marketCap":4081035590},{"date":"2021-04-23","current":-9.959524,"twenty":-41.603839,"median":-12.153966,"eighty":-4.484863,"marketCap":4030957832},{"date":"2021-04-30","current":-10.280057,"twenty":-41.603839,"median":-12.153966,"eighty":-4.484863,"marketCap":4160688673},{"date":"2021-05-07","current":-9.045746,"twenty":-41.603839,"median":-12.153966,"eighty":-4.484863,"marketCap":3825843922},{"date":"2021-05-14","current":-8.679414,"twenty":-41.603839,"median":-12.153966,"eighty":-4.484863,"marketCap":3670906176},{"date":"2021-05-21","current":-9.035316,"twenty":-41.603839,"median":-12.153966,"eighty":-4.484863,"marketCap":3821432752},{"date":"2021-05-28","current":-8.886067,"twenty":-41.603839,"median":-12.153966,"eighty":-4.484863,"marketCap":3758308704},{"date":"2021-06-04","current":-8.794221,"twenty":-41.603839,"median":-12.153966,"eighty":-4.484863,"marketCap":3719463136},{"date":"2021-06-11","current":-9.279281,"twenty":-41.603839,"median":-12.153966,"eighty":-4.484863,"marketCap":3924616292},{"date":"2021-06-18","current":-9.528987,"twenty":-41.886515,"median":-12.156103,"eighty":-4.484848,"marketCap":4030227680},{"date":"2021-06-25","current":-9.859057,"twenty":-42.169191,"median":-12.15824,"eighty":-4.484834,"marketCap":4169828940},{"date":"2021-07-02","current":-10.223569,"twenty":-42.169191,"median":-12.15824,"eighty":-4.484834,"marketCap":4323997288},{"date":"2021-07-09","current":-9.742815,"twenty":-42.169191,"median":-12.15824,"eighty":-4.484834,"marketCap":4120665018},{"date":"2021-07-16","current":-9.198916,"twenty":-42.169191,"median":-12.15824,"eighty":-4.484834,"marketCap":3890626420},{"date":"2021-07-23","current":-9.260625,"twenty":-42.169191,"median":-12.15824,"eighty":-4.484834,"marketCap":3916725786},{"date":"2021-07-30","current":-8.946341,"twenty":-42.169191,"median":-12.15824,"eighty":-4.484834,"marketCap":3783801108},{"date":"2021-08-06","current":-8.911899,"twenty":-42.169191,"median":-12.15824,"eighty":-4.484834,"marketCap":3769234020},{"date":"2021-08-13","current":-6.261215,"twenty":-42.169191,"median":-12.15824,"eighty":-4.515928,"marketCap":3031123266},{"date":"2021-08-20","current":-5.778031,"twenty":-42.169191,"median":-12.15824,"eighty":-4.589647,"marketCap":2797208252},{"date":"2021-08-27","current":-6.403774,"twenty":-42.560394,"median":-12.168081,"eighty":-4.738949,"marketCap":3100137356},{"date":"2021-09-03","current":-7.486208,"twenty":-42.560394,"median":-12.168081,"eighty":-4.821907,"marketCap":3624155845},{"date":"2021-09-10","current":-7.460977,"twenty":-42.560394,"median":-12.168081,"eighty":-4.985722,"marketCap":3611940962},{"date":"2021-09-17","current":-7.563165,"twenty":-42.560394,"median":-12.168081,"eighty":-5.398384,"marketCap":3661411239},{"date":"2021-09-24","current":-7.705723,"twenty":-42.560394,"median":-12.168081,"eighty":-5.998303,"marketCap":3730425329},{"date":"2021-10-01","current":-7.512702,"twenty":-42.560394,"median":-12.168081,"eighty":-6.399485,"marketCap":3636981472},{"date":"2021-10-08","current":-7.507655,"twenty":-42.560394,"median":-12.168081,"eighty":-6.5973,"marketCap":3634538496},{"date":"2021-10-15","current":-8.041303,"twenty":-42.560394,"median":-12.168081,"eighty":-7.142214,"marketCap":3892883275},{"date":"2021-10-22","current":-7.781418,"twenty":-42.560394,"median":-12.168081,"eighty":-7.437732,"marketCap":3767069978},{"date":"2021-10-29","current":-7.313372,"twenty":-42.560394,"median":-12.168081,"eighty":-7.456687,"marketCap":3540483895},{"date":"2021-11-05","current":-7.947946,"twenty":-42.560394,"median":-12.168081,"eighty":-7.491254,"marketCap":3847688208},{"date":"2021-11-12","current":-6.309721,"twenty":-42.560394,"median":-12.168081,"eighty":-7.491254,"marketCap":3678472813},{"date":"2021-11-19","current":-6.244499,"twenty":-42.560394,"median":-12.168081,"eighty":-7.491254,"marketCap":3640449253},{"date":"2021-11-26","current":-6.040417,"twenty":-42.560394,"median":-12.168081,"eighty":-7.491254,"marketCap":3521472306},{"date":"2021-12-03","current":-5.593329,"twenty":-42.560394,"median":-12.168081,"eighty":-7.491254,"marketCap":3260826933},{"date":"2021-12-10","current":-5.549146,"twenty":-42.560394,"median":-12.168081,"eighty":-7.491254,"marketCap":3235069038},{"date":"2021-12-17","current":-9.709434,"twenty":-42.560394,"median":-12.168081,"eighty":-7.521798,"marketCap":5660454513},{"date":"2021-12-23","current":-9.553595,"twenty":-42.560394,"median":-12.168081,"eighty":-7.55282,"marketCap":5569602407},{"date":"2021-12-31","current":-9.788135,"twenty":-42.560394,"median":-12.168081,"eighty":-7.577547,"marketCap":5706335771},{"date":"2022-01-07","current":-9.820945,"twenty":-42.451867,"median":-12.163161,"eighty":-7.624343,"marketCap":5725463346},{"date":"2022-01-14","current":-9.764976,"twenty":-42.451867,"median":-12.163161,"eighty":-7.668908,"marketCap":5692834361},{"date":"2022-01-21","current":-9.610797,"twenty":-42.451867,"median":-12.163161,"eighty":-7.701938,"marketCap":5602950743},{"date":"2022-01-28","current":-9.481964,"twenty":-42.451867,"median":-12.163161,"eighty":-7.747355,"marketCap":5527842514},{"date":"2022-02-04","current":-9.721679,"twenty":-42.451867,"median":-12.163161,"eighty":-7.810031,"marketCap":5667593071},{"date":"2022-02-11","current":-9.926546,"twenty":-42.451867,"median":-12.163161,"eighty":-7.899161,"marketCap":5787027468},{"date":"2022-02-18","current":-9.853681,"twenty":-42.451867,"median":-12.163161,"eighty":-7.947946,"marketCap":5744548223},{"date":"2022-02-25","current":-9.952483,"twenty":-42.451867,"median":-12.163161,"eighty":-8.165309,"marketCap":5802148128},{"date":"2022-03-04","current":-9.405454,"twenty":-42.451867,"median":-12.163161,"eighty":-8.3041,"marketCap":5797831971},{"date":"2022-03-11","current":-10.001609,"twenty":-42.451867,"median":-12.163161,"eighty":-8.385663,"marketCap":6165321906}],"updateTime":1752903354391}}}